<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">101531</article-id><article-id pub-id-type="doi">10.7554/eLife.101531</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.101531.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>The triad interaction of ULK1, ATG13, and FIP200 is required for ULK complex formation and autophagy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hama</surname><given-names>Yutaro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7190-4547</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Fujioka</surname><given-names>Yuko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6905-0669</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Hayashi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2831-1463</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Mizushima</surname><given-names>Noboru</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6258-6444</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund15"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Noda</surname><given-names>Nobuo N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6940-8069</contrib-id><email>nn@igm.hokudai.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund16"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e16g702</institution-id><institution>Institute for Genetic Medicine, Hokkaido University</institution></institution-wrap><addr-line><named-content content-type="city">Sapporo</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution>Institute of Microbial Chemistry</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Department of Biochemistry and Molecular Biology, Graduate School of Medicine, The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00krab219</institution-id><institution>Department of Molecular Oncology, Nippon Medical School, Institute for Advanced Medical Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yu</surname><given-names>Li</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03cve4549</institution-id><institution>Tsinghua University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ron</surname><given-names>David</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>06</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP101531</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-07-28"><day>28</day><month>07</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-08-06"><day>06</day><month>08</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.08.02.606296"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-10-01"><day>01</day><month>10</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.101531.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-06"><day>06</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.101531.2"/></event></pub-history><permissions><copyright-statement>© 2024, Hama et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Hama et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-101531-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-101531-figures-v2.pdf"/><abstract><p>In mammals, autophagosome formation, a central event in autophagy, is initiated by the ULK complex comprising ULK1/2, FIP200, ATG13, and ATG101. However, the structural basis and mechanism underlying the ULK complex assembly have yet to be fully clarified. Here, we predicted the core interactions organizing the ULK complex using AlphaFold, which proposed that the intrinsically disordered region of ATG13 engages the bases of the two UBL domains in the FIP200 dimer via two phenylalanines and also binds the tandem microtubule-interacting and transport domain of ULK1, thereby yielding the 1:1:2 stoichiometry of the ULK1–ATG13–FIP200 complex. We validated the predicted interactions by point mutations and demonstrated direct triad interactions among ULK1, ATG13, and FIP200 in vitro and in cells, wherein each interaction was additively important for autophagic flux. These results indicate that the ULK1–ATG13–FIP200 triadic interaction is crucial for autophagosome formation and provides a structural basis and insights into the regulation mechanism of autophagy initiation in mammals.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>autophagy</kwd><kwd>AlphaFold</kwd><kwd>ULK complex</kwd><kwd>ATG13</kwd><kwd>FIP200</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP19H05707</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP23K20044</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP23K06667</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP24H00060</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP25H00966</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP25H01320</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP25H01321</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP23K14140</award-id><principal-award-recipient><name><surname>Hama</surname><given-names>Yutaro</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP22KJ0044</award-id><principal-award-recipient><name><surname>Hama</surname><given-names>Yutaro</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP21H05731</award-id><principal-award-recipient><name><surname>Fujioka</surname><given-names>Yuko</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP23H02429</award-id><principal-award-recipient><name><surname>Fujioka</surname><given-names>Yuko</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP23K27122</award-id><principal-award-recipient><name><surname>Fujioka</surname><given-names>Yuko</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP23H04923</award-id><principal-award-recipient><name><surname>Fujioka</surname><given-names>Yuko</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP21H05256</award-id><principal-award-recipient><name><surname>Yamamoto</surname><given-names>Hayashi</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP22H04919</award-id><principal-award-recipient><name><surname>Mizushima</surname><given-names>Noboru</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002241</institution-id><institution>Japan Science and Technology Agency</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.52926/jpmjcr20e3</award-id><principal-award-recipient><name><surname>Noda</surname><given-names>Nobuo N</given-names></name></principal-award-recipient></award-group><award-group id="fund17"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002241</institution-id><institution>Japan Science and Technology Agency</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.52926/jpmjer1702</award-id><principal-award-recipient><name><surname>Mizushima</surname><given-names>Noboru</given-names></name></principal-award-recipient></award-group><award-group id="fund18"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP20gm6410009</award-id><principal-award-recipient><name><surname>Fujioka</surname><given-names>Yuko</given-names></name></principal-award-recipient></award-group><award-group id="fund19"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007449</institution-id><institution>Takeda Science Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fujioka</surname><given-names>Yuko</given-names></name><name><surname>Noda</surname><given-names>Nobuo</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>AlphaFold-guided in vitro and in vivo analyses establish the mechanism of ULK complex formation and provide a structural basis for understanding its role in mammalian autophagy initiation.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Macroautophagy (hereafter autophagy) is an intracellular degradation system delivering cytoplasmic components to the lysosome via autophagosomes (<xref ref-type="bibr" rid="bib27">Mizushima and Komatsu, 2011</xref>). Autophagy contributes to intracellular quality control by degrading defective proteins and organelles, such as polyubiquitinated proteins and damaged mitochondria. Alternatively, autophagy is induced by starvation as an adaptation mechanism. These physiological roles of autophagy are associated with various diseases, including cancer and neurodegenerative disorders (<xref ref-type="bibr" rid="bib28">Mizushima and Levine, 2020</xref>). Therefore, understanding and controlling autophagy in clinical contexts is essential.</p><p>Autophagosome formation is performed by the evolutionarily conserved autophagy-related (ATG) proteins, which form several functional units to act directly on autophagosome formation (<xref ref-type="bibr" rid="bib29">Nakatogawa, 2020</xref>). Among them, the Atg1/ULK complex is critical in initiating autophagosome formation by organizing the formation site where all the functional units, such as ATG9 vesicles and ATG8 conjugation system, colocalize (<xref ref-type="bibr" rid="bib10">Hama et al., 2023</xref>; <xref ref-type="bibr" rid="bib18">Kannangara et al., 2021</xref>; <xref ref-type="bibr" rid="bib20">Kishi-Itakura et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Ren et al., 2023</xref>; <xref ref-type="bibr" rid="bib41">Suzuki et al., 2001</xref>; <xref ref-type="bibr" rid="bib46">Yamamoto et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Zhou et al., 2021</xref>). In mammals, the ULK complex includes ULK1/2, ATG13, ATG101, and RB1CC1/FIP200 (<xref ref-type="bibr" rid="bib26">Mizushima, 2010</xref>; <xref ref-type="bibr" rid="bib45">Wong et al., 2013</xref>). Structural and functional analysis has made considerable progress in the yeast counterpart, the Atg1 complex, whose core comprises Atg1 (ULK1/2 homolog), Atg13, and Atg17 (remote homolog of FIP200) (<xref ref-type="bibr" rid="bib7">Fujioka et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Li et al., 2014</xref> <xref ref-type="bibr" rid="bib23">Lin and Hurley, 2016</xref>; <xref ref-type="bibr" rid="bib30">Noda, 2024</xref>; <xref ref-type="bibr" rid="bib34">Ragusa et al., 2012</xref>). Crystallographic analyses have unveiled the detailed interaction mode of Atg13 with Atg1 and Atg17 and the mechanism of the Atg1 complex organization (<xref ref-type="bibr" rid="bib7">Fujioka et al., 2014</xref>). Moreover, structure-based in vitro and in vivo functional analyses have revealed that the Atg1 complex undergoes liquid–liquid phase separation to organize the autophagosome formation site on the vacuolar membrane to initiate autophagy (<xref ref-type="bibr" rid="bib8">Fujioka et al., 2020</xref>). However, structural and functional analyses of the mammalian ULK complex lag behind that of the yeast Atg1 complex, and structural information on the interactions comprising the core of the ULK complex has long been limited to low-resolution electron microscopy (EM) data (<xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>). A recent preprint reported the cryo-EM structures of the human ULK1 core complex and the supercomplex between the ULK1 core complex and the class III phosphatidylinositol 3-kinase complex 1 at 4.2–6.84 Å resolution, which discovered the unprecedented interaction between these two critical complexes working at autophagy initiation (<xref ref-type="bibr" rid="bib4">Chen et al., 2023</xref>). Moreover, the local resolution of 3.35 Å enabled them to resolve the ULK1-mediated interactions in the ULK1 core complex. However, not all of the interactions that construct the ULK1 core complex have been perfectly resolved. Recently, calcium transients on the endoplasmic reticulum surface were proposed to trigger the liquid–liquid phase separation of FIP200 to organize the autophagosome formation site, thereby initiating autophagy (<xref ref-type="bibr" rid="bib50">Zheng et al., 2022</xref>). However, the lack of structural information makes elucidating the molecular mechanisms underlying these events challenging.</p><p>This study predicted the structure of the ULK1–ATG13–FIP200 complex using the AlphaFold2 multimer (<xref ref-type="bibr" rid="bib6">Evans et al., 2021</xref>), which unveiled the detailed interactions between ATG13 and FIP200, ATG13 and ULK1, and ULK1 and FIP200. In vitro and in vivo mutational analysis confirmed all the predicted interactions, which were demonstrated to be important for autophagy. Furthermore, we found that the FIP200–ATG13 and ULK1–ATG13 interactions partially complement each other for autophagy initiation. These findings establish the mechanism of ULK complex formation and provide a structural basis for understanding the ULK complex phase separation and regulation mechanism of autophagy in the mammalian context.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Structural prediction of the ULK1–ATG13–FIP200 complex identifies FIP200-interacting residues in ATG13</title><p>Previous studies reported that the C-terminal region of ULK1 and the C-terminal intrinsically disordered region of ATG13 bind to the N-terminal region of the FIP200 homodimer and that the stoichiometry of the ULK1–ATG13–FIP200 complex is 1:1:2 (<xref ref-type="bibr" rid="bib1">Alers et al., 2011</xref>; <xref ref-type="bibr" rid="bib9">Ganley et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Hieke et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Hosokawa et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Jung et al., 2009</xref>; <xref ref-type="bibr" rid="bib32">Papinski and Kraft, 2016</xref>; <xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Wallot-Hieke et al., 2018</xref>). However, the structural details underlying the ULK complex assembly, particularly the role of the intrinsically disordered region of ATG13, remain elusive. To understand the mechanism of the ULK complex formation, we predicted the structure of the FIP200 [1–634 amino acids (aa)] dimer complexed with ATG13 (isoform c, 363–517 aa) and ULK1 (801–1050 aa) (underlined regions in <xref ref-type="fig" rid="fig1">Figure 1A</xref>) by AlphaFold2 with the AlphaFold-Multimer option, during which the appropriateness of the regions chosen for our predictions as interaction interfaces was further corroborated by AlphaFold2 models of full-length ATG13 with full-length ULK1 and of full-length ATG13 with the FIP200 (residues 1–634) dimer (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). <xref ref-type="fig" rid="fig1">Figure 1B</xref> depicts the predicted overall structure of the ULK1–ATG13–FIP200 complex, with flexible FIP200 loop regions that received low pLDDT scores omitted for clarity. The overall structure is consistent with the low-resolution cryo-EM model reported previously (<xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>), including the C-shape of the FIP200 dimer and the binding of one molecule each of ATG13 and ULK1 to the FIP200 dimer, resulting in the 1:1:2 stoichiometry of the ULK1–ATG13–FIP200 complex. The two FIP200 molecules are named FIP200<sup>A</sup> and FIP200<sup>B</sup>, where FIP200<sup>A</sup> is the one close to ULK1. Extensive interactions were predicted between the four molecules, with a buried surface area of 3658 Å<sup>2</sup> for FIP200<sup>A</sup>–FIP200<sup>B</sup>, 2195 Å<sup>2</sup> for FIP200<sup>A</sup>–ATG13, 1966 Å<sup>2</sup> for FIP200<sup>B</sup>–ATG13, 2140 Å<sup>2</sup> for ATG13–ULK1, and 1681 Å<sup>2</sup> for FIP200<sup>A</sup>–ULK1. No interaction was observed between FIP200<sup>B</sup> and ULK1. One ATG13 molecule binds to the FIP200 dimer through the interaction of residues 365–398 and 394–482 with FIP200<sup>B</sup> and FIP200<sup>A</sup>, respectively, resulting in a 1:2 stoichiometry of the ATG13–FIP200 complex.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Structural basis of the ATG13–FIP200 interaction.</title><p>(<bold>A</bold>) Domain architecture of ULK1, ATG13, and FIP200. Regions used for the AlphaFold2 complex prediction are underlined. (<bold>B</bold>) Structure of the ULK1–ATG13–FIP200 core complex predicted by AlphaFold2. Flexible loop regions in FIP200 were removed from the figure for clarity. N and C indicate N- and C-terminal regions, respectively. (<bold>C</bold>) Close-up view of the interactions between ATG13 and FIP200. The bottom panels represent the surface model of FIP200 with the coloring based on the electrostatic potentials (blue and red indicate positive and negative potentials, respectively). (<bold>D</bold>) Isothermal titration calorimetry (ITC) results obtained by titration of MBP-ATG13 (363–517 aa) WT or FIP3A mutant into an FIP200 (1–634 aa) solution. (<bold>E</bold>) Effect of the ATG13 FIP3A mutation on the FIP200 interaction in vivo. ATG13 KO HeLa cells stably expressing FLAG-tagged ATG13 WT or FIP3A were immunoprecipitated with an anti-FLAG antibody and detected with anti-FIP200, anti-ULK1, and anti-FLAG antibodies. (<bold>F</bold>) Relative amounts of precipitated FIP200 in (<bold>E</bold>) were calculated. Solid bars indicate the means, and dots indicate the data from three independent experiments. Differences were statistically analyzed using Tukey’s multiple comparisons test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig1">Figure 1E</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101531-fig1-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig1">Figure 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101531-fig1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Values used for preparation of the graph in <xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-101531-fig1-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>AlphaFold2 prediction of the ULK1–ATG13–FIP200 core complex.</title><p>(<bold>A</bold>) AlphaFold2 model of the full-length ULK1–ATG13 complex. (<bold>B</bold>) AlphaFold2 model of the full-length ATG13 complexed with the homodimer of FIP200 (1–634). (<bold>C</bold>) Predicted aligned error (PAE) plot of (<bold>A</bold>) (left), (<bold>B</bold>) (middle), and (<bold>D</bold>) (right). (<bold>D</bold>) Structure of the ULK1–ATG13–FIP200 core complex with flexible loops. (<bold>E</bold>) The structure in (<bold>D</bold>), color-coded by pLDDT values. (<bold>F</bold>) Cryo-EM structures of the ULK1–ATG13–FIP200 core complex.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Purification of recombinant proteins.</title><p>SDS–PAGE of recombinant proteins used for isothermal titration calorimetry (ITC) and in vitro pull-down experiments. Protein bands were stained with Coomassie Brilliant Blue.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101531-fig1-figsupp2-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata2"><label>Figure 1—figure supplement 2—source data 2.</label><caption><title>Original file for SDS–PAGE analysis displayed in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101531-fig1-figsupp2-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig1-figsupp2-v2.tif"/></fig></fig-group><p>We compared our AlphaFold2 prediction model with the cryo-EM structures reported as a preprint recently (<xref ref-type="bibr" rid="bib4">Chen et al., 2023</xref>). For the ULK1–ATG13–FIP200 complex, PDB entries 8SOI, 8SRM, and 8SQZ have global resolutions of 4.2, 4.46, and 5.85 Å, respectively, and employ different ATG13 segments (residues 462–517, 450–517, and 363–517) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). Despite these differences, all three cryo-EM models contain only the MIM region of ATG13 (residues 462–517). The ULK1 and FIP200 regions used also vary slightly, but are essentially the same as those we used for our AlphaFold2 calculations. In every structure, FIP200 forms a C-shaped dimer whose overall architecture resembles our AlphaFold2 model. While the C-shape opening angle differs among the structures, this variation is consistent with reports that FIP200 can adopt multiple conformations (<xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>). The mode of ULK1 binding to FIP200 is likewise fundamentally conserved (a detailed comparison is given below). The main difference among the three structures is their stoichiometry: ULK1:ATG13:FIP200 is 1:1:2 in 8SOI, whereas it is 2:2:2 in the other two entries. In our AlphaFold2 model, ATG13 residues 365–390 bind one FIP200 protomer, and residues 442–472 bind the equivalent region of the second protomer, accounting for an ATG13:FIP200 stoichiometry of 1:2. Consequently, a 2:2 stoichiometry is not inconsistent when only the MIM segment of ATG13 is present. Conversely, PDB 8SQZ uses the same ATG13 segment (residues 363–517) as our AlphaFold2 calculations yet displays an ATG13:FIP200 stoichiometry of 2:2. Because this stoichiometry is observed only after the complex has been mixed with PI3KC3-C1 (<xref ref-type="bibr" rid="bib4">Chen et al., 2023</xref>), some additional regulatory mechanism by PI3KC1-C1 is presumably involved, although its details remain unclear.</p><p>Previous studies using hydrogen–deuterium exchange coupled to mass spectrometry identified three regions (M1–M3) in ATG13 responsible for FIP200 binding (<xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>). Among these sites, the side chain of Phe377 in M1 and Phe453 in M3 was deeply inserted into the hydrophobic pockets formed at the base of UBL domains (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Direct interaction between FIP200 (1–634) and Atg13 (363–517) was confirmed by isothermal titration calorimetry (ITC) with a <italic>K</italic><sub>D</sub> value of 6.6 μM, which was severely attenuated by alanine substitution at these three phenylalanine sites (F377A, F394A, F453A; FIP3A) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Furthermore, the ATG13<sup>FIP3A</sup> mutant expressed in <italic>ATG13</italic> KO cells displayed a significantly reduced coprecipitation rate of the endogenous FIP200 (<xref ref-type="fig" rid="fig1">Figure 1E, F</xref>). These results confirm that ATG13 and FIP200 interact with each other via the residues predicted by AlphaFold2 in vitro and in vivo.</p></sec><sec id="s2-2"><title>ULK1 and ATG13 interact via MIT–MIM interaction similar to yeast Atg1–Atg13</title><p>Next, we focused on the interaction between ULK1 and ATG13. We previously determined the crystal structure of the yeast Atg1–Atg13 complex, which revealed that the tandem microtubule-interacting and transport (MIT) domains in Atg1 bind to the tandem MIT-interacting motifs (MIMs) of ATG13 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, right; <xref ref-type="bibr" rid="bib7">Fujioka et al., 2014</xref>). The predicted structure of the ULK1–ATG13 complex (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, left) was quite similar to that of the yeast Atg1–Atg13 complex and to the cryo-EM structures of the ULK1–ATG13 portion of the ULK1 core complex (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, middle). The assembly is stabilized by two sets of the ULK1<sup>MIT1</sup>–ATG13<sup>MIM(C)</sup> and ULK1<sup>MIT2</sup>–ATG13<sup>MIM(N)</sup> interactions (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Phe470 of ATG13<sup>MIM(N)</sup> and Phe512 of ATG13<sup>MIM(C)</sup> were inserted into the hydrophobic pocket of ULK1<sup>MIT2</sup> and ULK1<sup>MIT1</sup>, respectively (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Direct interaction between ULK1 (636–1050) and Atg13 (363–517) was confirmed by ITC with a <italic>K</italic><sub>D</sub> value of 0.34 μM, which was severely attenuated by alanine substitution at these two phenylalanine sites (F470A, F512A; ULK2A) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). In <italic>ATG13</italic> KO cells, the ULK1 expression level was significantly reduced, suggesting that the lack of ATG13 severely destabilized ULK1. This mirrors the ATG13-mediated stabilization of ATG101, another component of the ULK complex (<xref ref-type="bibr" rid="bib42">Suzuki et al., 2015</xref>). The exogenous expression of ATG13<sup>WT</sup>, but not of the ATG13<sup>ULK2A</sup> mutant, rescued the endogenous ULK1 expression (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>), indicating that the ULK2A mutation in ATG13 attenuates the ATG13–ULK1 interaction in vivo. These observations confirm that, like the yeast Atg1–Atg13 interaction, the ULK1–ATG13 interaction is mediated by MIT–MIM contacts.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Structural basis of the ULK1–ATG13 interaction.</title><p>(<bold>A</bold>) AlphaFold2 model of the ULK1–ATG13 moiety of the ULK1–ATG13–FIP200 core complex in <xref ref-type="fig" rid="fig1">Figure 1B</xref> (left), Cryo-EM structure of the ULK1–ATG13 moiety of the ULK1–ATG13–FIP200 core complex (PDB 8SOI), and crystal structure of the yeast Atg1–Atg13 complex (right, PDB 4P1N). (<bold>B</bold>) Close-up view of the interactions between ATG13<sup>MIM(N)</sup> and ULK1<sup>MIT2</sup> and between ATG13<sup>MIM(C)</sup> and ULK1<sup>MIT1</sup> (right). (<bold>C</bold>) Isothermal titration calorimetry (ITC) results obtained by titration of MBP-ULK1 (636–1050 aa) into a solution of WT or ULK2A mutant of MBP-ATG13 (363–517 aa). Due to weak binding, the <italic>K</italic><sub>D</sub> value for the ULK2A mutant was not accurately determined. (<bold>D</bold>) Effect of the ATG13–FIP3A mutation on endogenous ULK1 levels in vivo. WT or <italic>ATG13</italic> KO HeLa cells stably expressing FLAG-tagged ATG13 WT or ULK2A mutant were lysed, and indicated proteins were detected by immunoblotting using anti-FIP200, anti-ULK1, and anti-FLAG antibodies. (<bold>E</bold>) Relative amounts of ULK1 in (<bold>D</bold>) were normalized with β-actin and calculated. Solid bars indicate the means, and dots indicate the data from three independent experiments. Differences were statistically analyzed using Tukey’s multiple comparisons test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101531-fig2-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101531-fig2-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Values used for preparation of the graph in <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-101531-fig2-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig2-v2.tif"/></fig></sec><sec id="s2-3"><title>Direct interaction between ULK1 and FIP200 is essential for autophagy</title><p>Although AlphaFold2 predicted the direct interaction between ULK1 and FIP200 over a reasonably large contact area (1681 Å<sup>2</sup>) and similar interaction was observed in cryo-EM structures (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>; <xref ref-type="bibr" rid="bib4">Chen et al., 2023</xref>), a previous study reported that ULK1 required ATG13–ATG101 for FIP200 binding in vitro (<xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>). ULK1<sup>MIT1</sup> and ULK1<sup>MIT2</sup> interact directly with FIP200, with the Leu967 of ULK1<sup>MIT1</sup> and Phe997 of ULK1<sup>MIT2</sup> inserted on the hydrophobic groove of FIP200 (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). Although we failed to measure the affinity between ULK1 and FIP200 by ITC due to aggregation upon their mixing, an in vitro pull-down assay indicated that ULK1 directly interacted with FIP200, which was significantly attenuated by the FIP2A (L967A, F997A) mutation (<xref ref-type="fig" rid="fig3">Figure 3C, D</xref>). Consistently, the ULK1<sup>FIP2A</sup> mutant lost the interaction with FIP200 while partially retaining the interaction with ATG13 in cells (<xref ref-type="fig" rid="fig3">Figure 3E, F</xref>). We confirmed that the ULK1<sup>FIP2A</sup> mutant retains substantial affinity with ATG13 in vitro by ITC (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). These results confirm the direct ULK1–FIP200 interaction in vitro and in vivo. Our results establish the mode of the three independent interactions within the ULK complex, ATG13–FIP200, ATG13–ULK1, and ULK1–FIP200, operating both in vitro and in vivo.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Structural basis of the ULK1–FIP200 interaction.</title><p>(<bold>A</bold>) Structure of the ULK1–FIP200 moiety of the ULK1–ATG13–FIP200 core complex in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. The right panel represents the surface model of FIP200 with coloring based on the electrostatic potentials (blue and red indicate positive and negative potentials, respectively). Dotted squares indicate the regions displayed in (<bold>B</bold>). (<bold>B</bold>) Close-up view of the interactions between ULK1<sup>MIT1</sup> and FIP200 (top) and between ULK1<sup>MIT2</sup> and FIP200 (bottom). Left and right indicate AlphaFold2 and cryo-EM (PDB 8SOI) models. (<bold>C</bold>) In vitro pull-down assay between GST-ULK1 (636–1050 aa) WT or FIP2A mutant with MBP-FIP200 (1–634 aa). (<bold>D</bold>) Relative amounts of precipitated MBP-FIP200 in (<bold>C</bold>) were calculated. Solid bars indicate the means, and dots indicate the data from three independent experiments. Differences were statistically analyzed using Tukey’s multiple comparisons test. (<bold>E</bold>) Effect of the ULK1 FIP2A mutation on the FIP200 interaction in vivo. Ulk1,2 DKO mouse embryonic fibroblasts (MEFs) stably expressing FLAG-tagged ULK1 WT or FIP2A mutant were immunoprecipitated with an anti-FLAG antibody and detected with anti-FIP200, anti-ATG13, and anti-FLAG antibodies. (<bold>F</bold>) Relative amounts of precipitated FIP200 (left) and ATG13 (right) in (<bold>E</bold>) were calculated. Solid bars indicate the means, and dots indicate the data from three independent experiments. Differences were statistically analyzed using Tukey’s multiple comparisons test. (<bold>G</bold>) Halo-LC3 processing assay of ULK1 FIP2A-expressing cells. <italic>Ulk1,2</italic> DKO MEFs stably expressing Halo-LC3 and FLAG-tagged ULK1 WT or FIP2A mutant were labeled for 15 min with 100 nm tetramethylrhodamine (TMR)-conjugated Halo ligand and incubated in starvation medium for 1 hr. Cell lysates were subjected to in-gel fluorescence detection. (<bold>H</bold>) Halo processing rate in (<bold>G</bold>). The band intensity of processed Halo and Halo-LC3 in each cell line was quantified, and the relative cleavage rate was calculated as FLAG-ULK1 WT-expressing cells as 1. Solid bars indicate the means, and dots indicate the data from three independent experiments. Data were statistically analyzed using Tukey’s multiple comparisons test. (<bold>I</bold>) Colocalization of FLAG-ULK1 WT or FIP2A mutant with FIP200. <italic>Ulk1,2</italic> DKO MEFs stably expressing FLAG-tagged ULK1 WT or FIP2A mutant were immunostained with anti-FLAG and anti-FIP200 antibodies. Scale bar, 10 μm.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>PDF file containing original western blots or SDS–PAGE for <xref ref-type="fig" rid="fig3">Figure 3C, E, G</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101531-fig3-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Original files for western blot or SDS–PAGE analysis displayed in <xref ref-type="fig" rid="fig3">Figure 3C, E, G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101531-fig3-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Values used for preparation of the graph in <xref ref-type="fig" rid="fig3">Figure 3D, F, H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-101531-fig3-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Isothermal titration calorimetry (ITC) analysis between ULK1 and ATG13.</title><p>ITC results obtained by titration of MBP-ULK1 (636–1050 aa) FIP2A mutant into a solution of WT MBP-ATG13 (363–517 aa). Although the <italic>K</italic><sub>D</sub> value for the ULK2A mutant was not determined precisely; these data indicate that the mutant retains substantial affinity for ATG13.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To investigate the physiological importance of the ULK1–FIP200 interaction, we assessed autophagy flux using the Halo-LC3 processing assay (<xref ref-type="bibr" rid="bib36">Rudinskiy et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Yim et al., 2022</xref>). <italic>Ulk1,2</italic> DKO mouse embryonic fibroblasts (MEFs) expressing FLAG-tagged wild-type ULK1 produce a stronger band of cleaved Halo than cells which do not express ULK1. The intensity of this cleaved Halo band corresponds to the amount of Halo-LC3 delivered to lysosomes in an autophagy-dependent manner. <italic>Ulk1,2</italic> DKO MEFs expressing the ULK1<sup>FIP2A</sup> mutant had partially but significantly reduced processed Halo bands upon starvation compared to ULK1<sup>WT</sup>-expressing cells, confirming that the direct ULK1–FIP200 interaction is crucial, although partially, for autophagy activity (<xref ref-type="fig" rid="fig3">Figure 3G, H</xref>). This partial phenotype would be due to an indirect interaction between ULK1 and FIP200 via ATG13, which was supported by the observation that the ULK1<sup>FIP2A</sup> mutant colocalized with FIP200 in cells, although less efficiently than ULK1<sup>WT</sup> (<xref ref-type="fig" rid="fig3">Figure 3I</xref>).</p></sec><sec id="s2-4"><title>Triadic ULK1–ATG13–FIP200 interactions are critical for autophagic flux</title><p>We compared the autophagic flux of impaired ATG13–ULK1 and ATG13–FIP200 interactions to confirm the hypothesis that indirect triadic complexes are functional for autophagy. We generated knock-in (KI) cell lines that included <italic>ATG13<sup>FIP3A</sup></italic>, <italic>ATG13<sup>ULK2A</sup></italic>, and <italic>ATG13<sup>FU5A</sup></italic> (F377A, F394A, F453A, F470A, F512A; FU5A) followed by a 3xFLAG-tag in the genomic <italic>ATG13</italic> locus of HeLa cells (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). Since overexpressed ATG13-FLAG is more than 20-fold higher than its endogenous level, the mutation significance can be evaluated at more physiological expression levels using the KI cell lines (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). The ATG13<sup>FIP3A</sup> and ATG13<sup>ULK2A</sup> KI cells displayed partial colocalization with FIP200, whereas the ATG13<sup>FU5A</sup> KI cells displayed scarce colocalization with FIP200 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Next, we expressed Halo-LC3 in these KI cells and performed a Halo processing assay. Cleaved Halo was partially reduced in ATG13<sup>FIP3A</sup> and ATG13<sup>ULK2A</sup> KI cells compared to ATG13<sup>WT</sup> cells. In contrast, cleaved Halo in ATG13<sup>FU5A</sup> KI cells was almost equivalent to that in the knockout cells (<xref ref-type="fig" rid="fig4">Figure 4D, E</xref>). Note that ATG13<sup>WT</sup> KI cells show a ~25% reduction in cleaved Halo compared to WT HeLa cells, suggesting that FLAG-tag KI only partially affects autophagic flux. These results suggest that ATG13–ULK1 and ATG13–FIP200 bindings complement each other in autophagy function and that ULK1, ATG13, and FIP200 directly bind to each other to organize the robust ULK complex.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>ATG13–ULK1 and ATG13–FIP200 interactions complement each other in autophagy function.</title><p>(<bold>A</bold>) Schematic representation of the CRISPR–Cas9-mediated KI strategy of ATG13 mutations with FLAG tag. The C-terminally FLAG-tagged coding sequence after exon 14 of ATG13 with or without FIP3A, ULK2A, or FU5A mutations were knocked in exon 14 of the <italic>Homo sapiens ATG13</italic> locus. As the KI cassette expresses NeoR under the hPGK1 promoter, clones that were successfully knocked in were selected by G418. Cas9-gRNA-targeted sites in the exon 14 of <italic>H. sapiens ATG13</italic> locus are displayed in dark blue. The homology arm for KI is presented in magenta, and the ATG13 CDS and mutations in red and cyan, respectively. NeoR is displayed in brown. Scale bar, 0.5 kilobase pair (kb). (<bold>B</bold>) Immunoblot of ATG13-FLAG KI cell lines. WT, <italic>ATG13</italic> KO, and indicated KI HeLa cells were lysed, and indicated proteins were detected by immunoblotting using anti-FIP200, anti-ULK1, and anti-FLAG antibodies. (<bold>C</bold>) Colocalization of endogenous levels of ATG13-FLAG mutants with FIP200. Indicated KI cell lines were cultured in the starvation medium for 1 hr and immunostained with anti-FLAG and anti-FIP200 antibodies. Scale bar, 10 μm. (<bold>D</bold>) Halo-LC3 processing assay of ATG13-FLAG KI cell lines. WT, ATG13 KO and KI HeLa cell lines were labeled for 15 min with 100 nm tetramethylrhodamine (TMR)-conjugated Halo ligand and incubated in starvation medium for 1 hr. Cell lysates were subjected to in-gel fluorescence detection. (<bold>E</bold>) Halo processing rate in (<bold>D</bold>). The band intensity of processed Halo and Halo-LC3 in each cell line was quantified, and the relative cleavage rate was calculated as WT HeLa cells as 1. Solid bars indicate the means, and dots indicate the data from three independent experiments. Data were statistically analyzed using Tukey’s multiple comparisons test. (<bold>F</bold>) Schematic depiction of the difference between the mammalian ULK complex and the yeast Atg1 complex. Mammalian ATG13 binds to two FIP200s within the same FIP200 dimer, contributing to the stability of one ULK complex. Conversely, budding yeast Atg13 binds to two Atg17s within a different Atg17 dimer, allowing for endlessly repeated Atg13–Atg17 interactions. ATG101 in the ULK complex and Atg31-29 in the Atg1 complex are omitted for simplicity. ATG13/Atg13 is shown in yellow, ULK1/Atg1 in magenta, and FIP200/Atg17 in green. Black lines represent interactions.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig4">Figure 4B, D</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101531-fig4-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig4">Figure 4B, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101531-fig4-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Values used for preparation of the graph in <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-101531-fig4-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Stable overexpression of <italic>ATG13</italic> results in 10-fold higher protein expression than the endogenous version.</title><p>(<bold>A</bold>) Comparison of <italic>ATG13</italic> expression level. WT, <italic>ATG13</italic> KO stably expressing ATG13-FLAG, and ATG13-FLAG KI HeLa cells were lysed, and indicated proteins were detected by immunoblotting using anti-ATG13, anti-FIP200, anti-ULK1, and anti-β-actin antibodies. (<bold>B</bold>) Relative amounts of ATG13 in (<bold>A</bold>) were calculated as WT HeLa cells as 1. Solid bars indicate the means, and dots indicate the data from three independent experiments. Differences were statistically analyzed using Tukey’s multiple comparisons test. (<bold>C</bold>) Colocalization of ATG9A and FIP200 in ATG13-FLAG KI cells. Indicated KI cell lines expressing ATG9A-HA were cultured in the starvation medium for 1 hr and immunostained with anti-FLAG, anti-FIP200, and anti-p62 antibodies. Scale bar, 10 μm. (<bold>D</bold>) ULK1-dependent phosphorylation of ATG14 in ATG13-FLAG KI cell lines. WT, ATG13 KO and KI HeLa cell lines cultured in the starvation medium for 1 hr. Indicated proteins were detected by immunoblotting using anti-ATG14 phospho-S29, anti-ATG14, and anti-β-actin antibodies. (<bold>E</bold>) ATG14 phosphorylation rate in (<bold>D</bold>). The band intensity of p-ATG14 and ATG14 in each cell line was quantified, and the phosphorylation rate was calculated as WT HeLa cells as 1. Solid bars indicate the means, and dots indicate the data from three independent experiments. Data were statistically analyzed using Tukey’ s multiple comparisons test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, D</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101531-fig4-figsupp1-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101531-fig4-figsupp1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Values used for preparation of the graph in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B, E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-101531-fig4-figsupp1-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101531-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Finally, we investigated how disrupting the ULK complex leads to impaired autophagy. One well-established function of the ULK complex is to recruit ATG9 vesicles (<xref ref-type="bibr" rid="bib35">Ren et al., 2023</xref>). These vesicles serve as an upstream platform for the PI3KC3-C1, providing the substrate for phosphoinositide generation (<xref ref-type="bibr" rid="bib13">Holzer et al., 2024</xref>). To clarify how our mutations impact this step, we starved ATG13 mutant KI cells and observed ATG9A localization. Unexpectedly, even in ATG13<sup>FU5A</sup> KI cells, where ATG13 is almost completely dissociated from the ULK complex, ATG9A still colocalized with FIP200 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Since these puncta also overlapped with p62, it is likely that p62 bodies recruit both FIP200 and ATG9 vesicles (<xref ref-type="bibr" rid="bib10">Hama et al., 2023</xref>). Therefore, it is apparently difficult to assess the autophagosome formation-associated recruitment of the ATG9 vesicles using the present KI cell lines. Another key function of the ULK complex is the ULK1-dependent phosphorylation of ATGs, and phosphorylation of ATG14 at Ser29 is known to be particularly critical (<xref ref-type="bibr" rid="bib33">Park et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Wold et al., 2016</xref>). In ATG13<sup>FIP3A</sup> and ATG13<sup>FU5A</sup> KI cells, ATG14 phosphorylation was significantly reduced, indicating decreased ULK1 activity (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D, E</xref>). Notably, in <italic>ATG13</italic> KO cells, ATG14 phosphorylation became almost undetectable, though the underlying mechanism remains to be fully investigated. Altogether, these data point to reduced ULK1 activity as a key factor explaining the autophagy deficiency observed in ATG13<sup>FU5A</sup> KI cells.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The interaction mechanism of ULK1–ATG13–FIP200, the core of the ULK complex, has been extensively studied (<xref ref-type="bibr" rid="bib1">Alers et al., 2011</xref>; <xref ref-type="bibr" rid="bib4">Chen et al., 2023</xref>; <xref ref-type="bibr" rid="bib9">Ganley et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Hieke et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Hosokawa et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Jung et al., 2009</xref>; <xref ref-type="bibr" rid="bib32">Papinski and Kraft, 2016</xref>; <xref ref-type="bibr" rid="bib39">Shi et al., 2020</xref>). However, most of these studies either lacked structural context or, when structural analyses were performed, they were not adequately validated by functional assays in both in vitro and in vivo settings, leaving our understanding of the interaction mechanism still limited. In this study, AlphaFold2-based point mutational analysis provides solid evidence for the direct ULK1–ATG13, ATG13–FIP200, and ULK1–FIP200 bindings in vitro and in vivo. Additionally, the triadic interaction is complementary in the cell.</p><p>Regarding the importance of triadic interactions for the molecular function of the ULK complex, we observed their partial significance for ULK1 kinase activity against ATG14, a component of PI3KC3-C1, in our assays (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D, E</xref>). This observation is consistent with recent work showing that FIP200 interacts with the PI3KC3-C1 (<xref ref-type="bibr" rid="bib4">Chen et al., 2023</xref>). In contrast, we were unable to evaluate autophagosome formation-associated recruitment of the ATG9 vesicles in our ATG13 KI cell lines (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). However, given the direct interaction between ATG13 and ATG9A, it is likely that recruitment fails in ATG13<sup>FU5A</sup> KI cells. In the future, recruitment should be reevaluated under conditions that prevent p62 body-mediated recruitment, such as a penta-receptor KO genetic background.</p><p>One major structural difference between the mammalian ULK complex we predicted here and the yeast Atg1 complex is that one ATG13 binds to two FIP200s within the same FIP200 dimer in mammals, whereas one Atg13 binds to two Atg17s in the distinct Atg17 dimers in yeast (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). The latter binding mode of Atg13 bridges Atg17 dimers to each other to form a higher-order assemblage (<xref ref-type="bibr" rid="bib47">Yamamoto et al., 2016</xref>), which is considered to be the Atg1 complex’s phase separation mechanism (<xref ref-type="bibr" rid="bib8">Fujioka et al., 2020</xref>). Conversely, ATG13 cannot bridge FIP200 dimers to each other and thus cannot induce a higher-order assemblage of the ULK complex, which necessitates another mechanism for phase separation. A recent study reported that calcium transients on the endoplasmic reticulum surface trigger FIP200 phase separation (<xref ref-type="bibr" rid="bib50">Zheng et al., 2022</xref>); however, the detailed mechanisms are unresolved. Further studies are required to elucidate the mechanisms of phase separation in organizing the autophagosome formation sites in mammals.</p><p>In addition to Atg17, budding and fission yeasts have Atg11 as a closer homolog of FIP200 (<xref ref-type="bibr" rid="bib19">Kim et al., 2001</xref>; <xref ref-type="bibr" rid="bib22">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Sun et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Yorimitsu and Klionsky, 2005</xref>). Atg11 and Atg17 interact with Atg1 and Atg13, respectively, whereas Atg11–Atg13 and Atg17–Atg1 interactions have not been reported. <italic>Arabidopsis thaliana</italic>, which belongs to the Archaeplastida group, a supergroup distant from Opisthokonta (including yeasts and mammals), also has Atg1, Atg13, and Atg11 (<xref ref-type="bibr" rid="bib3">Burki et al., 2020</xref>; <xref ref-type="bibr" rid="bib22">Li et al., 2014</xref>). The <italic>A. thaliana</italic> Atg11 interacts with Atg13 but not with Atg1 (<xref ref-type="bibr" rid="bib22">Li et al., 2014</xref>). The triadic interaction of Atg1/ULK1, ATG13, and Atg11/Atg17/FIP200 has not been reported for any species other than mammals. This triadic interaction is likely beneficial for cells that form the complicated cellular communities that comprise the metazoans. The most likely physiological significance is the fine-tuning of tissue-specific autophagic activity. Consistent with this idea, several splicing variants of ATG13 are present in vertebrates (<xref ref-type="bibr" rid="bib2">Alers et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Hieke et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Jung et al., 2009</xref>). In humans, at least five splicing variants are known, including the isoform 3 lacking the C-terminal ULK1-binding site (MIMs, <xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib2">Alers et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Jung et al., 2009</xref>). The avian Atg13 has seven splicing variants, some lacking parts of the FIP200 interaction site (<xref ref-type="bibr" rid="bib2">Alers et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Hieke et al., 2015</xref>). This study found that a single disruption of the FIP200–ATG13 or ULK1–ATG13 interaction results in a partial reduction of autophagy activity (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). In the individual context, the tissue- and organ-specific fine-tuning of the autophagy activity may occur by regulating the expression amount and ratio of splicing variants that lack some of the triad interactions. Generating KI mice with the point mutations identified in this study might help investigate the significance of the triadic binding at the individual level.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">ULK1</td><td align="left" valign="bottom">NCBI Reference Sequence</td><td align="left" valign="bottom">NM_003565.4</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">ATG13 (isoform c)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Hosokawa et al., 2009</xref></td><td align="left" valign="bottom">NM_001142673.3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">RB1CC1/FIP200 (isoform 2)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">Hara et al., 2008</xref></td><td align="left" valign="bottom">NM_001083617.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">ATG9A</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib20">Kishi-Itakura et al., 2014</xref></td><td align="left" valign="bottom">NM_001077198.3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Rattus norvegicus</italic>)</td><td align="left" valign="bottom">MAP1LC3B</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Yim et al., 2022</xref></td><td align="left" valign="bottom">NM_022867.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21 (DE3)</td><td align="left" valign="bottom">Novagen</td><td align="left" valign="bottom">69450</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HEK293T</td><td align="left" valign="bottom">RIKEN</td><td align="left" valign="bottom">RCB2202</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HeLa</td><td align="left" valign="bottom">RIKEN</td><td align="left" valign="bottom">RCB0007</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Ulk1 Ulk2</italic> DKO MEF</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Cheong et al., 2011</xref></td><td align="left" valign="bottom">Kindly provided by Craig B, Thompson</td><td align="left" valign="bottom">Established from C57BL/6 mice</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom"><italic>ATG13</italic> KO HeLa</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib10">Hama et al., 2023</xref></td><td align="left" valign="bottom">WM1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">ATG13-3xFLAG KI HeLa</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">13FWTKI14</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">ATG13-3xFLAG FIP3A KI HeLa</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">13FF3AKI12</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">ATG13-3xFLAG ULK2A KI HeLa</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">13FU2AKI12</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">ATG13-3xFLAG FU5A KI HeLa</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">13FFU5AKI24</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-FIP200</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">17250-1-AP</td><td align="left" valign="bottom">1:1000 for WB, 1:500 for IF</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit monoclonal anti-ATG13</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#13273</td><td align="left" valign="bottom">1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-ULK1</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#8054S</td><td align="left" valign="bottom">1:500 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-ATG14 p-Ser29</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#92340</td><td align="left" valign="bottom">1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-ATG14</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">24412-1-AP</td><td align="left" valign="bottom">1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Guinea pig polyclonal anti-p62</td><td align="left" valign="bottom">PROGEN</td><td align="left" valign="bottom">GP62-C</td><td align="left" valign="bottom">1:500 for IF</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-FLAG</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">M185-7</td><td align="left" valign="bottom">1:1000 for WB, 1:500 for IF</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-HA</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">M180-3</td><td align="left" valign="bottom">1:500 for IF</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-β-actin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A2228</td><td align="left" valign="bottom">1:10,000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP-conjugated mouse monoclonal anti-DDDDK tag</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">M185-7</td><td align="left" valign="bottom">1:2000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP-conjugated mouse monoclonal anti-rabbit IgG</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">111-035-144</td><td align="left" valign="bottom">1:10,000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP-conjugated mouse monoclonal anti-mouse IgG</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">111-035-003</td><td align="left" valign="bottom">1:10,000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488-conjugated polyclonal anti-mouse IgG</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-11029</td><td align="left" valign="bottom">1:2000 for IF</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555-conjugated polyclonal anti-rabbit IgG</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-31572</td><td align="left" valign="bottom">1:2000 for IF</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647-conjugated polyclonal anti-pig IgG</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-21450</td><td align="left" valign="bottom">1:2000 for IF</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b</td><td align="left" valign="bottom">Novagen</td><td align="left" valign="bottom">69661</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGEX-6P-1</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">28954648</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3">Figure 3C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b-MBP-ULK1 (636–1050 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig2">Figure 2C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b-MBP-ULK1<sup>FIP2A</sup> (636–1050 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b-MBP-ATG13 (363–517 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig1">Figures 1D</xref>, <xref ref-type="fig" rid="fig2">2C</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b-MBP-ATG13<sup>FIP3A</sup> (363–517 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig1">Figure 1D</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b-MBP-ATG13<sup>ULK2A</sup> (363–517 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig2">Figure 2C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET15b-MBP-FIP200 (1–634 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig1">Figures 1D</xref> and <xref ref-type="fig" rid="fig3">3C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGEX6p-1-GST-ULK1 (636–1050 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3">Figure 3C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGEX6p-1-GST-ULK1<sup>FIP2A</sup> (636–1050 aa)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3">Figure 3C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-3xFLAG-ULK1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE134</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3">Figure 3E, G</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-3xFLAG-ULK1<sup>FIP2A</sup></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE141</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3">Figure 3E, G</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-ATG13-3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE103</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig1">Figures 1D</xref>, <xref ref-type="fig" rid="fig2">2D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-ATG13<sup>FIP3A</sup>-3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE116</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig1">Figure 1D</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-ATG13<sup>ULK2A</sup>-3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE144</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig2">Figure 2D</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-ATG13<sup>FU5A</sup>-3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE180</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMRX-IP-ATG9A-3xHA</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHE218</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCG-gag-pol</td><td align="left" valign="bottom">Kindly provided by Teruhiko Yasui</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For packaging retrovirus for stable gene expression</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCG-VSV-G</td><td align="left" valign="bottom">Kindly provided by Teruhiko Yasui</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For packaging retrovirus for stable gene expression</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PX458-g<italic>ATG13</italic> exon14</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHC49</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pKnockIn</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHC3</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pKnockIn-<italic>ATG13</italic> exon14-ATG13 (347–517 aa)–3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHC50</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pKnockIn-<italic>ATG13</italic> exon14-ATG13<sup>FIP3A</sup> (347–517 aa)–3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHC51</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pKnockIn-<italic>ATG13</italic> exon14-ATG13<sup>ULK2A</sup> (347–517 aa)–3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHC52</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pKnockIn-<italic>ATG13</italic> exon14-ATG13<sup>FU5A</sup> (347–517 aa)–3xFLAG</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">YHC53</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">PrimeSTAR Max DNA Polymerase</td><td align="left" valign="bottom">Takara Bio</td><td align="left" valign="bottom">R045A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">NEBuilder HiFi DNA Assembly Master Mix</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E2621X</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FuGENE HD</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">VPE2311</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HaloTag TMR Ligand</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G8251</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Digitonin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D141</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Polybrane</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">H9268</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Puromycin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P8833</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Blasticidin</td><td align="left" valign="bottom">Fujifilm Wako Pure Chemical Corporation</td><td align="left" valign="bottom">022-18713</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">G-418</td><td align="left" valign="bottom">Fujifilm Wako Pure Chemical Corporation</td><td align="left" valign="bottom">074-06801</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Anti-FLAG M2 affinity gel</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A2220</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">4% paraformaldehyde</td><td align="left" valign="bottom">Fujifilm Wako Pure Chemical Corporation</td><td align="left" valign="bottom">163-20145</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Amylose Resin High Flow</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E8022L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bio-Scale Mini Bio-Gel P-6 desalting column</td><td align="left" valign="bottom">Bio-Rad Laboratories</td><td align="left" valign="bottom">7325304</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">COSMOGEL GST-Accept</td><td align="left" valign="bottom">NACALAI TESQUE</td><td align="left" valign="bottom">09277-14</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HiLoad 26/600 Superdex 200 pg</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">28989336</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">One Step CBB</td><td align="left" valign="bottom">BIO CRAFT</td><td align="left" valign="bottom">CBB-1000</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">AlphaFold2 v2.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Jumper et al., 2021</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Structural prediction was done using AlphaFold2 v2.3</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MicroCal PEAQ-ITC analysis software</td><td align="left" valign="bottom">Malvern Panalytical Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Integration and fitting of ITC were done using MicroCal PEAQ-ITC analysis software</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji-ImageJ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji/Downloads">https://imagej.net/Fiji/Downloads</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Image analysis was done using Fiji-ImageJ and plugins</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Illustrator</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Images were mounted using these softwares</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 9</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Graphs and statistical tests were done using GraphPad Prism</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Structural prediction using AlphaFold2 with the AlphaFold-Multimer mode</title><p>Structure was predicted using AlphaFold2 v2.3 installed on a local computer (Sunway Technology Co, Ltd) (<xref ref-type="bibr" rid="bib16">Jumper et al., 2021</xref>). The predictions were run using the AlphaFold-Multimer mode (<xref ref-type="bibr" rid="bib6">Evans et al., 2021</xref>), with five models and a single seed per model, and default multiple sequence alignment generation using the MMSeqs2 server (<xref ref-type="bibr" rid="bib25">Mirdita et al., 2022</xref>; <xref ref-type="bibr" rid="bib24">Mirdita et al., 2019</xref>). The unrelaxed predicted models were subjected to an Amber relaxation procedure, and the relaxed model with the highest confidence based on predicted LDDT scores was selected as the best model and used for figure preparation (<xref ref-type="bibr" rid="bib16">Jumper et al., 2021</xref>). Structural figures were prepared using PyMOL (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/pymol">http://www.pymol.org/pymol</ext-link>). The model is available in ModelArchive (<ext-link ext-link-type="uri" xlink:href="https://modelarchive.org/">https://modelarchive.org/</ext-link>) with the accession code ma-jz53c.</p></sec><sec id="s4-2"><title>Cell culture</title><p>HeLa cells and MEFs were cultured in Dulbecco’s modified Eagle medium (DMEM) (043-30085; Fujifilm Wako Pure Chemical Corporation) supplemented with 10% fetal bovine serum (FBS) (172012; Sigma-Aldrich) in a 5% CO<sub>2</sub> incubator at 37°C. Cells were washed twice with phosphate-buffered saline (PBS) and incubated in amino acid-free DMEM (048-33575; Fujifilm Wako Pure Chemical Corporation) without FBS for starvation. HeLa and HEK293T cells were authenticated and validated by STR profiling by RIKEN. <italic>ATG13</italic> KO HeLa cells (<xref ref-type="bibr" rid="bib10">Hama et al., 2023</xref>) and <italic>Ulk1 Ulk2</italic> double knockout MEFs (<xref ref-type="bibr" rid="bib5">Cheong et al., 2011</xref>) were described previously. <italic>Ulk1 Ulk2</italic> double knockout MEFs were originally derived from C57BL/6 mouse embryos and provided by an external researcher. The mammalian cell lines were routinely confirmed to be free of mycoplasma contamination by fluorescence microscopy.</p></sec><sec id="s4-3"><title>Plasmids for mammalian cells</title><p>Plasmids for stable expression were generated as follows: DNA fragments encoding human ULK1 (NM_003565.4), ATG13 (<xref ref-type="bibr" rid="bib14">Hosokawa et al., 2009</xref>), and ATG9A (<xref ref-type="bibr" rid="bib15">Itakura et al., 2012</xref>) were inserted into the retroviral plasmid pMRX-IP (puromycin-resistant marker) (<xref ref-type="bibr" rid="bib21">Kitamura et al., 2003</xref>; <xref ref-type="bibr" rid="bib37">Saitoh et al., 2003</xref>) with a 3 × FLAG or 3 × HA epitope tag. Site-directed mutagenesis was used to introduce ATG13<sup>FIP3A</sup>, ATG13<sup>ULK2A</sup>, ATG13<sup>FU5A</sup>, and ULK1<sup>FIP2A</sup> mutations. pMRXIB-HaloTag7-ratLC3B was described previously (<xref ref-type="bibr" rid="bib48">Yim et al., 2022</xref>). Plasmids for <italic>ATG13</italic> KI were generated as follows: sgRNAs targeting the exon 14 of <italic>ATG13</italic> (5′-<named-content content-type="sequence">GGCCTCCCCTCACGATGTCT</named-content>-3′) were inserted into the <italic>Bpi</italic>I site of PX458 [pSpCas9(BB)-2A-GFP; Addgene #48138]. Donor plasmids for <italic>ATG13</italic> KI were generated as follows: 500 base-pair (bp) and 682 bp homology arms were amplified from the genomic <italic>ATG13</italic> locus around exon 14 and inserted to flank the KI cassettes (described in <xref ref-type="fig" rid="fig4">Figure 4A</xref>) in the donor plasmid (pKnockIn). The coding sequence of 3xFLAG-tagged ATG13 with or without FIP3A, ULK2A, or FU5A mutations was amplified from stable expression plasmids (described above) and inserted just behind the 5′ homology arm.</p></sec><sec id="s4-4"><title>Stable expression in HeLa cells by retroviral infection</title><p>HEK293T cells were transfected with the retroviral plasmid with pCG-gag-pol and pCG-VSV-G (a gift from Dr. T. Yasui, National Institutes of Biomedical Innovation, Health and Nutrition) using FuGENE HD (E2311; Promega) for 4 hr in Opti-MEM (31985-070; Gibco). After cell cultivation for 2 days in DMEM, the retrovirus-containing medium was harvested, filtered through a 0.45-µm filter unit (Ultrafree-MC; Millipore), and added to HeLa cells or MEFs with 8 μg/ml polybrene (H9268; Sigma-Aldrich). After 24 hr, 2 μg/ml puromycin (P8833; Sigma-Aldrich) or 2.5 μg/ml blasticidin (022-18713; Fujifilm Wako Pure Chemical Corporation) was used to select the stable transformants.</p></sec><sec id="s4-5"><title>Plasmids for protein preparation</title><p>To construct the expression plasmid encoding an N-terminal maltose-binding protein (MBP) followed by an HRV3C protease site, the genes were amplified by PCR and cloned into the pET15b vector. The genes were amplified by PCR and cloned into the pET15b-MBP vector for the plasmids encoding N-terminal MBP-tagged ULK1, ATG13, and FIP200. Similarly, for the plasmids encoding N-terminal glutathione <italic>S</italic>-transferase (GST)-tagged ULK1, the genes were amplified by PCR and cloned into the pGEX6p-1 vector. The NEBuilder HiFi DNA Assembly Master Mix (New England BioLabs) was used to assemble the PCR fragments. PCR-mediated site-directed mutagenesis was used to introduce the mutations that led to the specified amino acid substitutions. All constructs were sequenced to confirm their identities.</p></sec><sec id="s4-6"><title>Protein expression and purification</title><p><italic>E. coli</italic> BL21 (DE3) cells were used to express all recombinant proteins. After cell lysis, MBP-FIP200 (1–634) was purified by affinity chromatography using Amylose Resin High Flow (New England Biolabs). Next, MBP was cleaved with the human rhinovirus 3C protease. The eluates were then desalted with 20 mM Tris-HCl, pH 8.0, and 150 mM NaCl utilizing a Bio-Scale Mini Bio-Gel P-6 desalting column (Bio-Rad Laboratories). Subsequently, the cleaved MBP was removed by reapplying FIP200 (1–634) to an Amylose Resin High Flow column. For the pull-down assay, MBP-FIP200 (1–634) eluted from the amylose resin continued to be purified on a HiLoad 26/60 Superdex 200 PG column eluted with 20 mM Tris-HCl, pH 8.0, and 150 mM NaCl.</p><p>Affinity chromatography with Amylose Resin High Flow (New England Biolabs) was used to purify the MBP-ATG13 (363–517) and MBP-ULK1 (636–1050) proteins. They were further purified on a HiLoad 26/60 Superdex 200 PG column and eluted with a buffer containing 20 mM Tris-HCl, pH 8.0, and 150 mM NaCl. Similarly, GST-ULK1 (636–1050) underwent initial purification using a GST-accept resin (Nacalai Tesque, 09277-14). This step was followed by further purification on a HiLoad 26/60 Superdex 200 PG column using the same elution buffer as above.</p></sec><sec id="s4-7"><title>In vitro pull-down assay</title><p>Purified proteins were incubated with GST-accept beads (Nacalai Tesque) at 4°C for 30 min. The beads were washed three times with PBS, and proteins were eluted with 10 mM glutathione in 50 mM Tris-HCl (pH 8.0). SDS–PAGE was used to separate the samples, and protein bands were detected by One Step CBB (BIO CRAFT).</p></sec><sec id="s4-8"><title>Isothermal titration calorimetry</title><p>The binding of FIP200 (1–634) to MBP-ATG13 (363–517) and MBP-ATG13 (363–517) to MBP-ULK1 (636–1050) was measured by ITC, with a MICROCAL PEAQ-ITC calorimeter (Malvern) and stirring at 750 rpm at 25°C. All proteins were prepared in a solution of 20 mM Tris-HCl, pH 8.0, and 150 mM NaCl. The titration of MBP-ATG13 (363–517) with FIP200 (1–634) involved 18 injections of 2 μl of the MBP-ATG13 (363–517) solution (229 μM) at 150-s intervals into a sample cell containing 300 μl of FIP200 (1–634) (4 μM). The titration of MBP-ULK1 (636–1050) with MBP-ATG13 (363–517) involved 18 injections of 2 μl of the MBP-ULK1 (636–1050) WT at 232 μM or FIP2A mutant at 172 μM at 150-s intervals into a sample cell containing 300 μl of MBP-ATG13 (363–517) at 22.9 or 20.0 μM, respectively. The isotherm was integrated and fitted with the one-side-binding model of the Malvern MicroCal PEAQ-ITC analysis software. The error of each parameter indicates the fitting error.</p></sec><sec id="s4-9"><title>Generation of KI cell lines</title><p>HeLa cells were transfected with the PX458-based plasmid expressing sgRNA for the <italic>ATG13</italic> gene and donor plasmids using FuGENE HD (E2311; Promega). One day after transfection, the KI cells were selected with 1 mg/ml G418 for 14 days. After single clones were isolated, clones positive for the FLAG tag and negative for wild-type ATG13 were screened by immunoblotting.</p></sec><sec id="s4-10"><title>Preparation of whole-cell lysates and immunoblotting</title><p>HeLa cells were lysed with 0.2% <italic>n</italic>-octyl-β-<sc>D</sc>-dodecyl maltoside in lysis buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, EDTA-free protease inhibitor cocktail (04080; Nacalai Tesque)] for 15 min on ice. After centrifugation at 20,000 × <italic>g</italic> for 15 min at 4°C, the supernatants were mixed with 20% volumes of 6 × SDS–PAGE sample buffer. The samples were subjected to SDS–PAGE and transferred to Immobilon-P PVDF membranes (IPVH00010; EMD Millipore). The primary antibodies used for immunoblotting were rabbit polyclonal antibodies against FIP200 (17250-1-AP; ProteinTech), ATG13 (13273; Cell Signaling), ULK1 (8054; Cell Signaling), ATG14 p-Ser29 (#92340; Cell Signaling), ATG14 (24412-1-AP; ProteinTech), and mouse monoclonal antibody against FLAG (F1804; Sigma-Aldrich) and β-actin (A2228; Sigma-Aldrich). Horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (111-035-144; Jackson ImmunoResearch) was used as a secondary antibody. The HRP-conjugated mouse monoclonal antibody against DDDDK-tag (M185-7; MBL) was used for FLAG tag detection. Immobilon Western Chemiluminescent HRP Substrate (P90715; EMD Millipore) was used to visualize the signals detected by an image analyzer (ImageQuant LAS 4000; Cytiva). Fiji software (ImageJ; National Institutes of Health) was used to adjust contrast and brightness and quantify the signals (<xref ref-type="bibr" rid="bib38">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-11"><title>Immunoprecipitation</title><p>Cells were lysed with 1% 3-[(3-cholamidopropyl)-dimethylammonium]-1-propanesulfonate (CHAPS) in lysis buffer and centrifuged at 20,000 × <italic>g</italic> for 15 min. The supernatants were incubated with anti-FLAG M2 affinity gel (A2220; Sigma-Aldrich) for 1 hr at 4°C with gentle rotation. The beads were washed three times in washing buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, and 0.5% CHAPS), and the proteins were eluted with the SDS–PAGE sample buffer.</p></sec><sec id="s4-12"><title>Immunostaining and fluorescence microscopy</title><p>Cells were grown on segmented cover glass (SCC-002; Matsunami Glass IND.), washed with PBS, and fixed with 4% paraformaldehyde (163-20145; Fujifilm Wako Pure Chemical Corporation) in PBS for 10 min. The cells were permeabilized with 50 µg/ml digitonin in PBS for 5 min and blocked with 3% BSA in PBS for 30 min. Primary antibodies in PBS and 3% BSA were added, and samples were incubated for 1 hr at room temperature. Cells were washed five times with PBS, incubated with secondary antibodies in PBS with 3% BSA for 1 hr at room temperature, and washed five times with PBS. Rabbit polyclonal antibodies against FIP200 (17250-1-AP; ProteinTech) and mouse monoclonal antibodies against FLAG (F1804; Sigma-Aldrich) HA (M180-3, MBL) and guinea pig antibody against p62 (GP62-C; PROGEN) were used as primary antibodies for immunostaining. Alexa Fluor 488-conjugated anti-mouse IgG (also cross-adsorbed to rabbit IgG and rat IgG) (A-11029; Thermo Fisher Scientific), Alexa Fluor 555-conjugated anti-rabbit IgG (also cross-adsorbed to mouse IgG) (A-31572; Thermo Fisher Scientific), and Alexa Fluor 647-conjugated anti-guinea pig (A21450; Thermo Fisher Scientific) were used as secondary antibodies. Cells were observed under a confocal microscope (ECLIPSE Ti2; Nikon).</p></sec><sec id="s4-13"><title>Halo-LC3 processing assay</title><p>Cells were treated with 100 nM tetramethylrhodamine (TMR)-conjugated HaloTag ligand (G8251, Promega) for 15 min. After washing twice with PBS, cells were cultured in the starvation medium for 1 hr and lysed as described above. Proteins were separated by SDS–PAGE, and in-gel TMR fluorescence was detected using a fluorescent imaging system (Odyssey M; Li-COR).</p></sec><sec id="s4-14"><title>Statistical analysis</title><p>GraphPad Prism 9 software (GraphPad Software) was used for statistical analyses. The statistical methods are described in each figure legend.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Funding acquisition, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Funding acquisition, Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Funding acquisition, Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-101531-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All the data underlying this study are available in the published article and its supplementary material.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Noda</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>ULK1 complex</data-title><source>ModelArchive</source><pub-id pub-id-type="accession" xlink:href="https://modelarchive.org/doi/10.5452/ma-jz53c">ma-jz53c</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Craig B Thompson for providing the <italic>Ulk1/2</italic> DKO MEFs; Shoji Yamaoka for the pMRXIP plasmid; Teruhito Yasui for the pCG-gag-pol and pCG-VSV-G plasmids; Sekiko Kurazono and Elijah William Caldwell for assistance with protein preparation. This work was supported in part by JSPS KAKENHI Grant Numbers JP19H05707, JP23K20044, JP23K06667, JP24H00060, JP25H00966, JP25H01320, and JP25H01321 (to NNN), JP23K14140, JP22KJ0044 (to YH), JP21H05731, JP23H02429, JP23K27122, JP23H04923 (to YF), JP21H05256 (to HY), JP22H04919 (to NM), CREST, Japan Science and Technology Agency Grant number JPMJCR20E3 (to NNN), ERATO, Japan Science and Technology Agency Grant number JPMJER1702 (to NM), PRIME, Japan Agency for Medical Research and Development Grant number JP20gm6410009 (to YF), and grants from the Takeda Science Foundation (to NNN, YF).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alers</surname><given-names>S</given-names></name><name><surname>Löffler</surname><given-names>AS</given-names></name><name><surname>Paasch</surname><given-names>F</given-names></name><name><surname>Dieterle</surname><given-names>AM</given-names></name><name><surname>Keppeler</surname><given-names>H</given-names></name><name><surname>Lauber</surname><given-names>K</given-names></name><name><surname>Campbell</surname><given-names>DG</given-names></name><name><surname>Fehrenbacher</surname><given-names>B</given-names></name><name><surname>Schaller</surname><given-names>M</given-names></name><name><surname>Wesselborg</surname><given-names>S</given-names></name><name><surname>Stork</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction</article-title><source>Autophagy</source><volume>7</volume><fpage>1423</fpage><lpage>1433</lpage><pub-id pub-id-type="doi">10.4161/auto.7.12.18027</pub-id><pub-id pub-id-type="pmid">22024743</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alers</surname><given-names>S</given-names></name><name><surname>Wesselborg</surname><given-names>S</given-names></name><name><surname>Stork</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ATG13: just a companion, or an executor of the autophagic program?</article-title><source>Autophagy</source><volume>10</volume><fpage>944</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.4161/auto.28987</pub-id><pub-id pub-id-type="pmid">24879146</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burki</surname><given-names>F</given-names></name><name><surname>Roger</surname><given-names>AJ</given-names></name><name><surname>Brown</surname><given-names>MW</given-names></name><name><surname>Simpson</surname><given-names>AGB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The new tree of eukaryotes</article-title><source>Trends in Ecology &amp; Evolution</source><volume>35</volume><fpage>43</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.tree.2019.08.008</pub-id><pub-id pub-id-type="pmid">31606140</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Khuu</surname><given-names>G</given-names></name><name><surname>Cook</surname><given-names>ASI</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yildiz</surname><given-names>A</given-names></name><name><surname>Lazarou</surname><given-names>M</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Structure and Activation of the Human Autophagy-Initiating ULK1C:PI3KC3-C1 Supercomplex</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.06.01.543278</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>H</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ammonia-induced autophagy is independent of ULK1/ULK2 kinases</article-title><source>PNAS</source><volume>108</volume><fpage>11121</fpage><lpage>11126</lpage><pub-id pub-id-type="doi">10.1073/pnas.1107969108</pub-id><pub-id pub-id-type="pmid">21690395</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>O’Neill</surname><given-names>M</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Antropova</surname><given-names>N</given-names></name><name><surname>Senior</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Blackwell</surname><given-names>S</given-names></name><name><surname>Yim</surname><given-names>J</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Protein complex prediction with alphafold-multimer</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.10.04.463034</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujioka</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>SW</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Kondo-Kakuta</surname><given-names>C</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Hirano</surname><given-names>H</given-names></name><name><surname>Akada</surname><given-names>R</given-names></name><name><surname>Inagaki</surname><given-names>F</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Structural basis of starvation-induced assembly of the autophagy initiation complex</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>21</volume><fpage>513</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2822</pub-id><pub-id pub-id-type="pmid">24793651</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujioka</surname><given-names>Y</given-names></name><name><surname>Alam</surname><given-names>JM</given-names></name><name><surname>Noshiro</surname><given-names>D</given-names></name><name><surname>Mouri</surname><given-names>K</given-names></name><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>May</surname><given-names>AI</given-names></name><name><surname>Knorr</surname><given-names>RL</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phase separation organizes the site of autophagosome formation</article-title><source>Nature</source><volume>578</volume><fpage>301</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-1977-6</pub-id><pub-id pub-id-type="pmid">32025038</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganley</surname><given-names>IG</given-names></name><name><surname>Lam</surname><given-names>DH</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>12297</fpage><lpage>12305</lpage><pub-id pub-id-type="doi">10.1074/jbc.M900573200</pub-id><pub-id pub-id-type="pmid">19258318</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Hama</surname><given-names>Y</given-names></name><name><surname>Kurikawa</surname><given-names>Y</given-names></name><name><surname>Matsui</surname><given-names>T</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>TAX1BP1 Recruits ATG9 Vesicles through SCAMP3 Binding</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.08.18.553817</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Takamura</surname><given-names>A</given-names></name><name><surname>Kishi</surname><given-names>C</given-names></name><name><surname>Iemura</surname><given-names>S-I</given-names></name><name><surname>Natsume</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>J-L</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells</article-title><source>The Journal of Cell Biology</source><volume>181</volume><fpage>497</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1083/jcb.200712064</pub-id><pub-id pub-id-type="pmid">18443221</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hieke</surname><given-names>N</given-names></name><name><surname>Löffler</surname><given-names>AS</given-names></name><name><surname>Kaizuka</surname><given-names>T</given-names></name><name><surname>Berleth</surname><given-names>N</given-names></name><name><surname>Böhler</surname><given-names>P</given-names></name><name><surname>Drießen</surname><given-names>S</given-names></name><name><surname>Stuhldreier</surname><given-names>F</given-names></name><name><surname>Friesen</surname><given-names>O</given-names></name><name><surname>Assani</surname><given-names>K</given-names></name><name><surname>Schmitz</surname><given-names>K</given-names></name><name><surname>Peter</surname><given-names>C</given-names></name><name><surname>Diedrich</surname><given-names>B</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name><name><surname>Holland</surname><given-names>P</given-names></name><name><surname>Simonsen</surname><given-names>A</given-names></name><name><surname>Wesselborg</surname><given-names>S</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Stork</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Expression of a ULK1/2 binding-deficient ATG13 variant can partially restore autophagic activity in ATG13-deficient cells</article-title><source>Autophagy</source><volume>11</volume><fpage>1471</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1068488</pub-id><pub-id pub-id-type="pmid">26213203</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>E</given-names></name><name><surname>Martens</surname><given-names>S</given-names></name><name><surname>Tulli</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The role of ATG9 vesicles in autophagosome biogenesis</article-title><source>Journal of Molecular Biology</source><volume>436</volume><elocation-id>168489</elocation-id><pub-id pub-id-type="doi">10.1016/j.jmb.2024.168489</pub-id><pub-id pub-id-type="pmid">38342428</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosokawa</surname><given-names>N</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Kaizuka</surname><given-names>T</given-names></name><name><surname>Kishi</surname><given-names>C</given-names></name><name><surname>Takamura</surname><given-names>A</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Iemura</surname><given-names>S</given-names></name><name><surname>Natsume</surname><given-names>T</given-names></name><name><surname>Takehana</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name><name><surname>Guan</surname><given-names>J-L</given-names></name><name><surname>Oshiro</surname><given-names>N</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy</article-title><source>Molecular Biology of the Cell</source><volume>20</volume><fpage>1981</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-12-1248</pub-id><pub-id pub-id-type="pmid">19211835</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itakura</surname><given-names>E</given-names></name><name><surname>Kishi-Itakura</surname><given-names>C</given-names></name><name><surname>Koyama-Honda</surname><given-names>I</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structures containing Atg9A and the ULK1 complex independently target depolarized mitochondria at initial stages of Parkin-mediated mitophagy</article-title><source>Journal of Cell Science</source><volume>125</volume><fpage>1488</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1242/jcs.094110</pub-id><pub-id pub-id-type="pmid">22275429</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>CH</given-names></name><name><surname>Jun</surname><given-names>CB</given-names></name><name><surname>Ro</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Otto</surname><given-names>NM</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Kundu</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery</article-title><source>Molecular Biology of the Cell</source><volume>20</volume><fpage>1992</fpage><lpage>2003</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-12-1249</pub-id><pub-id pub-id-type="pmid">19225151</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannangara</surname><given-names>AR</given-names></name><name><surname>Poole</surname><given-names>DM</given-names></name><name><surname>McEwan</surname><given-names>CM</given-names></name><name><surname>Youngs</surname><given-names>JC</given-names></name><name><surname>Weerasekara</surname><given-names>VK</given-names></name><name><surname>Thornock</surname><given-names>AM</given-names></name><name><surname>Lazaro</surname><given-names>MT</given-names></name><name><surname>Balasooriya</surname><given-names>ER</given-names></name><name><surname>Oh</surname><given-names>LM</given-names></name><name><surname>Soderblom</surname><given-names>EJ</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name><name><surname>Andersen</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters</article-title><source>EMBO Reports</source><volume>22</volume><elocation-id>e51136</elocation-id><pub-id pub-id-type="doi">10.15252/embr.202051136</pub-id><pub-id pub-id-type="pmid">34369648</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kamada</surname><given-names>Y</given-names></name><name><surname>Stromhaug</surname><given-names>PE</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Hefner-Gravink</surname><given-names>A</given-names></name><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>SV</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name><name><surname>Dunn</surname><given-names>WA</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cvt9/Gsa9 functions in sequestering selective cytosolic cargo destined for the vacuole</article-title><source>The Journal of Cell Biology</source><volume>153</volume><fpage>381</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1083/jcb.153.2.381</pub-id><pub-id pub-id-type="pmid">11309418</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi-Itakura</surname><given-names>C</given-names></name><name><surname>Koyama-Honda</surname><given-names>I</given-names></name><name><surname>Itakura</surname><given-names>E</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>4089</fpage><lpage>4102</lpage><pub-id pub-id-type="doi">10.1242/jcs.156034</pub-id><pub-id pub-id-type="pmid">25052093</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>T</given-names></name><name><surname>Koshino</surname><given-names>Y</given-names></name><name><surname>Shibata</surname><given-names>F</given-names></name><name><surname>Oki</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Nosaka</surname><given-names>T</given-names></name><name><surname>Kumagai</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics</article-title><source>Experimental Hematology</source><volume>31</volume><fpage>1007</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2003.07.005</pub-id><pub-id pub-id-type="pmid">14585362</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Chung</surname><given-names>T</given-names></name><name><surname>Vierstra</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>AUTOPHAGY-RELATED11 plays a critical role in general AUTOPHAGY- and senescence-induced mitophagy in Arabidopsis</article-title><source>The Plant Cell</source><volume>26</volume><fpage>788</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1105/tpc.113.120014</pub-id><pub-id pub-id-type="pmid">24563201</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>MG</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure and function of the ULK1 complex in autophagy</article-title><source>Current Opinion in Cell Biology</source><volume>39</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2016.02.010</pub-id><pub-id pub-id-type="pmid">26921696</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MMseqs2 desktop and local web server app for fast, interactive sequence searches</article-title><source>Bioinformatics</source><volume>35</volume><fpage>2856</fpage><lpage>2858</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty1057</pub-id><pub-id pub-id-type="pmid">30615063</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Schütze</surname><given-names>K</given-names></name><name><surname>Moriwaki</surname><given-names>Y</given-names></name><name><surname>Heo</surname><given-names>L</given-names></name><name><surname>Ovchinnikov</surname><given-names>S</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>ColabFold: making protein folding accessible to all</article-title><source>Nature Methods</source><volume>19</volume><fpage>679</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01488-1</pub-id><pub-id pub-id-type="pmid">35637307</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The role of the Atg1/ULK1 complex in autophagy regulation</article-title><source>Current Opinion in Cell Biology</source><volume>22</volume><fpage>132</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2009.12.004</pub-id><pub-id pub-id-type="pmid">20056399</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Komatsu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Autophagy: renovation of cells and tissues</article-title><source>Cell</source><volume>147</volume><fpage>728</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.026</pub-id><pub-id pub-id-type="pmid">22078875</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Autophagy in Human Diseases</article-title><source>The New England Journal of Medicine</source><volume>383</volume><fpage>1564</fpage><lpage>1576</lpage><pub-id pub-id-type="doi">10.1056/NEJMra2022774</pub-id><pub-id pub-id-type="pmid">33053285</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatogawa</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechanisms governing autophagosome biogenesis</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>21</volume><fpage>439</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0241-0</pub-id><pub-id pub-id-type="pmid">32372019</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noda</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Structural view on autophagosome formation</article-title><source>FEBS Letters</source><volume>598</volume><fpage>84</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.14742</pub-id><pub-id pub-id-type="pmid">37758522</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>ZQ</given-names></name><name><surname>Shao</surname><given-names>GC</given-names></name><name><surname>Liu</surname><given-names>XM</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Dong</surname><given-names>MQ</given-names></name><name><surname>Du</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Atg1 kinase in fission yeast is activated by Atg11-mediated dimerization and cis-autophosphorylation</article-title><source>eLife</source><volume>9</volume><elocation-id>e58073</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.58073</pub-id><pub-id pub-id-type="pmid">32909946</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papinski</surname><given-names>D</given-names></name><name><surname>Kraft</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation of autophagy by signaling through the Atg1/ULK1 complex</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>1725</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.03.030</pub-id><pub-id pub-id-type="pmid">27059781</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JM</given-names></name><name><surname>Jung</surname><given-names>CH</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Otto</surname><given-names>NM</given-names></name><name><surname>Grunwald</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Moriarity</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Starker</surname><given-names>C</given-names></name><name><surname>Nho</surname><given-names>RS</given-names></name><name><surname>Voytas</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14</article-title><source>Autophagy</source><volume>12</volume><fpage>547</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1080/15548627.2016.1140293</pub-id><pub-id pub-id-type="pmid">27046250</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragusa</surname><given-names>MJ</given-names></name><name><surname>Stanley</surname><given-names>RE</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Architecture of the Atg17 complex as a scaffold for autophagosome biogenesis</article-title><source>Cell</source><volume>151</volume><fpage>1501</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.11.028</pub-id><pub-id pub-id-type="pmid">23219485</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Lam</surname><given-names>WK</given-names></name><name><surname>Buffalo</surname><given-names>CZ</given-names></name><name><surname>Lazarou</surname><given-names>M</given-names></name><name><surname>Yokom</surname><given-names>AL</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Structural basis for ATG9A recruitment to the ULK1 complex in mitophagy initiation</article-title><source>Science Advances</source><volume>9</volume><elocation-id>eadg2997</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.adg2997</pub-id><pub-id pub-id-type="pmid">36791199</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudinskiy</surname><given-names>M</given-names></name><name><surname>Bergmann</surname><given-names>TJ</given-names></name><name><surname>Molinari</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Quantitative and time-resolved monitoring of organelle and protein delivery to the lysosome with a tandem fluorescent Halo-GFP reporter</article-title><source>Molecular Biology of the Cell</source><volume>33</volume><elocation-id>ar57</elocation-id><pub-id pub-id-type="doi">10.1091/mbc.E21-10-0526</pub-id><pub-id pub-id-type="pmid">35108065</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Yagita</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Yamaoka</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>36005</fpage><lpage>36012</lpage><pub-id pub-id-type="doi">10.1074/jbc.M304266200</pub-id><pub-id pub-id-type="pmid">12840022</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Yokom</surname><given-names>AL</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>LN</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ULK complex organization in autophagy by a C-shaped FIP200 N-terminal domain dimer</article-title><source>The Journal of Cell Biology</source><volume>219</volume><elocation-id>e201911047</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.201911047</pub-id><pub-id pub-id-type="pmid">32516362</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>LL</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Suo</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>XM</given-names></name><name><surname>Shen</surname><given-names>EZ</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Dong</surname><given-names>MQ</given-names></name><name><surname>He</surname><given-names>WZ</given-names></name><name><surname>Du</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Global analysis of fission yeast mating genes reveals new autophagy factors</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003715</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003715</pub-id><pub-id pub-id-type="pmid">23950735</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Kirisako</surname><given-names>T</given-names></name><name><surname>Kamada</surname><given-names>Y</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation</article-title><source>The EMBO Journal</source><volume>20</volume><fpage>5971</fpage><lpage>5981</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.21.5971</pub-id><pub-id pub-id-type="pmid">11689437</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Kaizuka</surname><given-names>T</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Noda</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structure of the Atg101-Atg13 complex reveals essential roles of Atg101 in autophagy initiation</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>22</volume><fpage>572</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3036</pub-id><pub-id pub-id-type="pmid">26030876</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallot-Hieke</surname><given-names>N</given-names></name><name><surname>Verma</surname><given-names>N</given-names></name><name><surname>Schlütermann</surname><given-names>D</given-names></name><name><surname>Berleth</surname><given-names>N</given-names></name><name><surname>Deitersen</surname><given-names>J</given-names></name><name><surname>Böhler</surname><given-names>P</given-names></name><name><surname>Stuhldreier</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Seggewiß</surname><given-names>S</given-names></name><name><surname>Peter</surname><given-names>C</given-names></name><name><surname>Gohlke</surname><given-names>H</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Stork</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Systematic analysis of ATG13 domain requirements for autophagy induction</article-title><source>Autophagy</source><volume>14</volume><fpage>743</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1387342</pub-id><pub-id pub-id-type="pmid">29173006</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wold</surname><given-names>MS</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Lachance</surname><given-names>V</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Yue</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ULK1-mediated phosphorylation of ATG14 promotes autophagy and is impaired in Huntington’s disease models</article-title><source>Molecular Neurodegeneration</source><volume>11</volume><elocation-id>76</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-016-0141-0</pub-id><pub-id pub-id-type="pmid">27938392</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>PM</given-names></name><name><surname>Puente</surname><given-names>C</given-names></name><name><surname>Ganley</surname><given-names>IG</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The ULK1 complex: sensing nutrient signals for autophagy activation</article-title><source>Autophagy</source><volume>9</volume><fpage>124</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.4161/auto.23323</pub-id><pub-id pub-id-type="pmid">23295650</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Kakuta</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>TM</given-names></name><name><surname>Kitamura</surname><given-names>A</given-names></name><name><surname>Sekito</surname><given-names>T</given-names></name><name><surname>Kondo-Kakuta</surname><given-names>C</given-names></name><name><surname>Ichikawa</surname><given-names>R</given-names></name><name><surname>Kinjo</surname><given-names>M</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Atg9 vesicles are an important membrane source during early steps of autophagosome formation</article-title><source>The Journal of Cell Biology</source><volume>198</volume><fpage>219</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1083/jcb.201202061</pub-id><pub-id pub-id-type="pmid">22826123</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Fujioka</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>SW</given-names></name><name><surname>Noshiro</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Kondo-Kakuta</surname><given-names>C</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Hirano</surname><given-names>H</given-names></name><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Noda</surname><given-names>NN</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The intrinsically disordered protein Atg13 mediates supramolecular assembly of autophagy initiation complexes</article-title><source>Developmental Cell</source><volume>38</volume><fpage>86</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.06.015</pub-id><pub-id pub-id-type="pmid">27404361</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>WW-Y</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A pulse-chasable reporter processing assay for mammalian autophagic flux with HaloTag</article-title><source>eLife</source><volume>11</volume><elocation-id>e78923</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.78923</pub-id><pub-id pub-id-type="pmid">35938926</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yorimitsu</surname><given-names>T</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Atg11 links cargo to the vesicle-forming machinery in the cytoplasm to vacuole targeting pathway</article-title><source>Molecular Biology of the Cell</source><volume>16</volume><fpage>1593</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1091/mbc.e04-11-1035</pub-id><pub-id pub-id-type="pmid">15659643</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Calcium transients on the ER surface trigger liquid-liquid phase separation of FIP200 to specify autophagosome initiation sites</article-title><source>Cell</source><volume>185</volume><fpage>4082</fpage><lpage>4098</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.09.001</pub-id><pub-id pub-id-type="pmid">36198318</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Gong</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Phosphorylation regulates the binding of autophagy receptors to FIP200 Claw domain for selective autophagy initiation</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1570</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21874-1</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101531.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Li</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03cve4549</institution-id><institution>Tsinghua University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>Building on previous structural studies, this work provides <bold>valuable</bold> new insights into the architecture of the autophagy initiation complex, comprising ULK1, ATG13, and FIP200. The authors present their findings with <bold>solid</bold> supporting evidence, making this study a significant contribution to the autophagy field.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101531.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>In this study, Hama et al. investigated the molecular regulatory mechanisms underlying the formation of the ULK1 complex in mammalian cells. Their results showed that in mammalian cells, ULK1, ATG13, and FIP200 form a complex with a stoichiometry of 1:1:2. These predicted interaction regions were validated through both in vivo and in vitro experiments, providing deeper insight into the molecular basis of ULK1 complex assembly in mammalian cells.</p><p>The revised manuscript has addressed the majority of my concerns, and I have no further questions. Overall, this is a solid and impactful study that significantly advances our understanding of how the ULK1 complex is formed.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101531.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This is important work that helps to uncover how the process of autophagy is initiated - via structural analyses of the initiating ULK1 complex. High resolution structural details and a mechanistic insight of this complex have been lacking and understanding how it assembles and functions is a major goal of a field that impacts many aspects of cell and disease biology. While we know components of the ULK1 complex are essential for autophagy, how they physically interact is far from clear. The work presented makes use of AlphaFold2 to structurally predict interaction sites between the different subunits of the ULK1 complex (namely ULK1, ATG13 and FIP200). Importantly, the authors go on to experimentally validate that these predicted sites are critical for complex formation by using site-directed mutagenesis and then go on to show that the three-way interaction between these components is necessary to induce autophagy in cells.</p><p>Strengths:</p><p>The data are very clear. Each binding interface of ATG13 (ATG13 with FIP300/ATG13 with ULK1) is confirmed biochemically with ITC and IP experiments from cells. Likewise, IP experiments with ULK1 and FIP200 also validate interaction domains. A real strength of the work is in the analyses of the consequences of disrupting ATG13's interactions in cells. The authors make CRISPR KI mutations of the binding interface point mutants. This is not a trivial task and is the best approach as everything is monitored under endogenous conditions. Using these cells the authors show that ATG13's ability to interact with both ULK1 and FIP200 is essential for a full autophagy response.</p><p>Weaknesses:</p><p>I think a main weakness here is the failure to acknowledge and compare results with an earlier preprint that shows essentially the same thing (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2023.06.01.543278">https://doi.org/10.1101/2023.06.01.543278</ext-link>). Arguably, this earlier work is much stronger from a structural point of view as it relies not only on AlphaFold2 but also actual experimental structural determinations (and takes the mechanisms of autophagy activation further by providing evidence for a super complex between the ULK1 and VPS34 complexes). That is not to say that this work is not important, as in the least it independently helps to build a consensus for ULK1 complex structure. Another weakness is that the downstream &quot;functional&quot; consequences of disrupting the ULK1 complex are only minimally addressed. The authors perform a Halotag-LC3 autophagy assay, which essentially monitors the endpoint of the process. There are a lot of steps in between, knowledge of which could help with mechanistic understanding. Not in the least is the kinase activity of ULK1 - how is this altered by disrupting its interactions with ATG13 and/or FIP200?</p><p>Update:</p><p>I feel the authors have addressed my concerns in their revised manuscript</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101531.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>In this study, the authors employed the protein complex structure prediction tool AlphaFold-Multimer to obtain a predicted structure of the protein complex composed of ULK1-ATG13-FIP200 and validated the structure using mutational analysis. This complex plays a central role in the initiation of autophagy in mammals. The results obtained in this study reveal extensive binary interactions between ULK1 and ATG13, between ULK1 and FIP200, and between ATG13 and FIP200, and pinpoint the critical residues at each interaction interface. Mutating these critical residues led to the loss of binary interactions. Interestingly, the authors showed that the ATG13-ULK1 interaction and the ATG13-FIP200 interaction are partially redundant for maintaining the complex. The experimental data presented by the authors are of high quality and convincing. The revised manuscript offers enhanced details about the prediction procedure and results, along with additional experimental findings, significantly increasing the scientific value of this paper.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101531.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hama</surname><given-names>Yutaro</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e16g702</institution-id><institution>Institute for Genetic Medicine, Hokkaido University</institution></institution-wrap><addr-line><named-content content-type="city">Sapporo</named-content></addr-line><country>Japan</country></aff><aff><institution>Institute of Microbial Chemistry</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Department of Biochemistry and Molecular Biology, Graduate School of Medicine, The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Fujioka</surname><given-names>Yuko</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e16g702</institution-id><institution>Institute for Genetic Medicine, Hokkaido University</institution></institution-wrap><addr-line><named-content content-type="city">Sapporo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Hayashi</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Department of Biochemistry and Molecular Biology, Graduate School of Medicine, The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00krab219</institution-id><institution>Department of Molecular Oncology, Nippon Medical School, Institute for Advanced Medical Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Mizushima</surname><given-names>Noboru</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Department of Biochemistry and Molecular Biology, Graduate School of Medicine, The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Noda</surname><given-names>Nobuo N</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e16g702</institution-id><institution>Institute for Genetic Medicine, Hokkaido University</institution></institution-wrap><addr-line><named-content content-type="city">Sapporo</named-content></addr-line><country>Japan</country></aff><aff><institution>Institute of Microbial Chemistry</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>In this study, Hama et al. explored the molecular regulatory mechanisms underlying the formation of the ULK1 complex. By employing the AlphaFold structural prediction tool, they showed notable differences in the complex formation mechanisms between ULK1 in mammalian cells and Atg1 in yeast cells. Their findings revealed that in mammalian cells, ULK1, ATG13, and FIP200 form a complex with a stoichiometry of 1:1:2. These predicted interaction regions were validated through both in vivo and in vitro assays, enhancing our understanding of the molecular mechanisms governing ULK1 complex formation in mammalian cells. Importantly, they identified a direct interaction between ULK1 and FIP200, which is crucial for autophagy. However, some aspects of this manuscript require further clarification, validation, and correction by the authors.</p></disp-quote><p>Thank you for your thorough evaluation of our manuscript. We have carefully revised the manuscript to address your concerns by performing extra experiments and providing additional clarifications, validations, and corrections as written below.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>This is important work that helps to uncover how the process of autophagy is initiated - via structural analyses of the initiating ULK1 complex. High-resolution structural details and a mechanistic insight of this complex have been lacking and understanding how it assembles and functions is a major goal of a field that impacts many aspects of cell and disease biology. While we know components of the ULK1 complex are essential for autophagy, how they physically interact is far from clear. The work presented makes use of AlphaFold2 to structurally predict interaction sites between the different subunits of the ULK1 complex (namely ULK1, ATG13, and FIP200). Importantly, the authors go on to experimentally validate that these predicted sites are critical for complex formation by using site-directed mutagenesis and then go on to show that the three-way interaction between these components is necessary to induce autophagy in cells.</p><p>Strengths:</p><p>The data are very clear. Each binding interface of ATG13 (ATG13 with FIP300/ATG13 with ULK1) is confirmed biochemically with ITC and IP experiments from cells. Likewise, IP experiments with ULK1 and FIP200 also validate interaction domains. A real strength of the work in in their analyses of the consequences of disrupting ATG13's interactions in cells. The authors make CRISPR KI mutations of the binding interface point mutants. This is not a trivial task and is the best approach as everything is monitored under endogenous conditions. Using these cells the authors show that ATG13's ability to interact with both ULK1 and FIP200 is essential for a full autophagy response.</p></disp-quote><p>Thank you for your thoughtful review and for highlighting the importance of our approach.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>I think a main weakness here is the failure to acknowledge and compare results with an earlier preprint that shows essentially the same thing (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2023.06.01.543278">https://doi.org/10.1101/2023.06.01.543278</ext-link>). Arguably this earlier work is much stronger from a structural point of view as it relies not only on AlphaFold2 but also actual experimental structural determinations (and takes the mechanisms of autophagy activation further by providing evidence for a super complex between the ULK1 and VPS34 complexes). That is not to say that this work is not important, as in the least it independently helps to build a consensus for ULK1 complex structure. Another weakness is that the downstream &quot;functional&quot; consequences of disrupting the ULK1 complex are only minimally addressed. The authors perform a Halotag-LC3 autophagy assay, which essentially monitors the endpoint of the process. There are a lot of steps in between, knowledge of which could help with mechanistic understanding. Not in the least is the kinase activity of ULK1 - how is this altered by disrupting its interactions with ATG13 and/or FIP200?</p></disp-quote><p>Thank you for this valuable feedback. In response, we performed a detailed structural comparison between the cryo-EM structure reported in the referenced preprint and our AlphaFold-based model. We have summarized both the similarities and differences in newly included figures (revised Figure 2A, B, 3B, S1F) and provided an in-depth discussion in the main text. Furthermore, to address the downstream consequences of ULK1 complex disruption, we have investigated the impact on ULK1 kinase activity, specifically examining how mutations affecting ATG13 or FIP200 interaction alter ULK1’s phosphorylation of a key substrate ATG14. In addition, we analyzed the effect on ATG9 vesicle recruitment. We provide the corresponding data as Figure S3C-E and detailed discussions in the revised manuscript.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>In this study, the authors employed the protein complex structure prediction tool AlphaFold-Multimer to obtain a predicted structure of the protein complex composed of ULK1-ATG13-FIP200 and validated the structure using mutational analysis. This complex plays a central role in the initiation of autophagy in mammals. Previous attempts at resolving its structure have failed to obtain high-resolution structures that can reveal atomic details of the interactions within the complex. The results obtained in this study reveal extensive binary interactions between ULK1 and ATG13, between ULK1 and FIP200, and between ATG13 and FIP200, and pinpoint the critical residues at each interaction interface. Mutating these critical residues led to the loss of binary interactions. Interestingly, the authors showed that the ATG13-ULK1 interaction and the ATG13-FIP200 interaction are partially redundant for maintaining the complex.</p></disp-quote><p>We are grateful for your high evaluation of our work.</p><disp-quote content-type="editor-comment"><p>The experimental data presented by the authors are of high quality and convincing. However, given the core importance of the AlphaFold-Multimer prediction for this study, I recommend the authors improve the presentation and documentation related to the prediction, including the following:</p><p>(1) I suggest the authors consider depositing the predicted structure to a database (e.g. ModelArchive) so that it can be accessed by the readers.</p></disp-quote><p>We have deposited the AlphaFold model to ModelArchive with the accession code ma-jz53c, which is indicated in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(2) I suggest the authors provide more details on the prediction, including explaining why they chose to use the 1:1:2 stoichiometry for ULK1-ATG13-FIP200 and whether they have tried other stoichiometries, and explaining why they chose to use the specific fragments of the three proteins and whether they have used other fragments.</p></disp-quote><p>We appreciate your suggestion. As we noted in the original manuscript, previous studies have shown that the C-terminal region of ULK1 and the C-terminal intrinsically disordered region of ATG13 bind to the N-terminal region of the FIP200 homodimer (Alers, Loffler et al., 2011; Ganley, Lam du et al., 2009; Hieke, Loffler et al., 2015; Hosokawa, Hara et al., 2009; Jung, Jun et al., 2009; Papinski and Kraft, 2016; Wallot-Hieke, Verma et al., 2018). We relied on these findings when determining the specific regions to include in our complex prediction and when selecting a 1:1:2 stoichiometry for ULK1–ATG13–FIP200 which was reported previously (Shi et al., 2020). We also used AlphaFold2 to predict the structures of the full-length ULK1–ATG13 complex and the complex of the FIP200N dimer with full-length ATG13, confirming that there were no issues with our choice of regions (revised Figure S1A-C). In the revised manuscript, we have provided a more detailed explanation of our rationale based on the previous reports and additional AlphaFold predictions.</p><disp-quote content-type="editor-comment"><p>(3) I suggest the authors present the PAE plot generated by AlphaFold-Multimer in Figure S1. The PAE plot provides valuable information on the prediction.</p></disp-quote><p>We provided the PAE plot in the revised Figure S1C.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>(1) In Figure 1D, the labels for the input and IP of ATG13-FLAG should be corrected to ATG13-FLAG FIP3A.</p></disp-quote><p>We thank the reviewer for pointing out these labeling mistakes. We revised the labels based on the suggestions.</p><disp-quote content-type="editor-comment"><p>(2) In the discussion section, the authors should address why ATG13-FLAG ULK1 2A in Fig. 2D leads to a significantly lower expression of ULK1 and provide possible explanations for this observation.</p></disp-quote><p>ATG13 and ATG101, both core components of the ULK1 complex, are known to stabilize each other through their mutual interaction. Loss or reduction of one protein typically leads to the destabilization of the other. In this context, ULK1 is similarly stabilized by binding to ATG13. Therefore, ATG13-FLAG ULK2A mutant, which has reduced binding to ULK1, likely loses this stabilizing activity and ULK1 becomes destabilized, resulting in the lower expression levels of ULK1. We added these discussions in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(3) In Figure 4B, the authors should explain why Atg13-FLAG KI significantly affects the expression of endogenous ULK1. Could Atg13-FLAG KI be interfering with its binding to ULK1? Experimental evidence should be provided to support this. Additionally, does Atg13-FLAG KI affect autophagy? Wild-type HeLa cells should be included as a control in Figure 4C and 4D to address this question.</p></disp-quote><p>Thank you for your constructive suggestion. We found a technical error in the ULK1 blot of Figure 4B. Therefore, we repeated the experiment. The results show that ULK1 expression did not significantly change in the ATG13-FLAG KI. These findings are consistent with Figure S3A. We have replaced Figure 4B with this new data.</p><p>We agree that including wild-type HeLa cells as a control is essential to determine whether ATG13-FLAG KI affects autophagy. We performed the same experiments in wild-type HeLa cells and found that ATG13-FLAG KI does not significantly impact autophagic flux. Accordingly, we have replaced Figures 4D and 4E with these new data.</p><disp-quote content-type="editor-comment"><p>(4) In Figure 3C, the authors used an in vitro GST pulldown assay to detect a direct interaction between ULK1 and FIP200, which was also confirmed in Figure 3E. However, since FLAG-ULK1 FIP2A affects its binding with ATG13 (Fig. 3E), it is possible that ULK1 FIP2A inhibits autophagy by disrupting this interaction. The authors should therefore use an in vitro GST pulldown assay to determine whether GST-ULK1 FIP2A affects its binding with ATG13. Additionally, the authors should investigate whether the interaction between ULK1 and FIP200 in cells requires the involvement of ATG13 by using ATG13 knockout cells to confirm if the ULK1-FIP200 interaction is affected in the absence of ATG13.</p></disp-quote><p>Thank you for the valuable suggestion. We examined the effect of the FIP2A mutation on the ULK1–ATG13 interaction using isothermal titration calorimetry (ITC) to obtain quantitative binding data. The results showed that the FIP2A mutation does not markedly alter the affinity between ULK1 and ATG13 (revised Figure S2B), suggesting that FIP2A mainly weakens the ULK1–FIP200 interaction. Regarding experiments in ATG13 knockout cells, ULK1 becomes destabilized in the absence of ATG13, making it technically difficult to assess how the ULK1–FIP200 interaction is affected under those conditions.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>I feel the manuscript would benefit from a more detailed comparison with the Hurely lab paper - are the structural binding interfaces the same, or are there differences?</p></disp-quote><p>We appreciate the suggestion to compare our results more closely with the work from the Hurley lab. We performed a detailed structural comparison between the cryo-EM structure reported in the referenced preprint and our AlphaFold-based model (revised Figure 2A, B, 3B, S1F) and provided an in-depth discussion in the main text.</p><disp-quote content-type="editor-comment"><p>As mentioned, what happens downstream of disrupting the ULK1 complex? How is ULK1 activity changed, both in vitro and in cells? Does disruption of the ULK1 complex binding sites impair VPS34 activity in cells (for example by looking at PtdIns3P levels/staining)?</p></disp-quote><p>Thank you for your insightful comments. We focused on elucidating how disrupting the ULK1 complex leads to impaired autophagy. To assess ULK1 activity, we measured ULK1-dependent phosphorylation of ATG14 at Ser29 (PMID: 27046250; PMID: 27938392). In FIP3A and FU5A knock-in cells, ATG14 phosphorylation was significantly reduced, indicating decreased ULK1 activity (revised Figure S3D, E). This observation is consistent with previous work showing that FIP200 recruits the PI3K complex. Notably, in ATG13 knockout cells, ATG14 phosphorylation became almost undetectable, though the underlying mechanism remains to be fully investigated. Altogether, these data point to reduced ULK1 activity as a key factor explaining the autophagy deficiency observed in FU5A knock-in cells.</p><p>We also explored possible downstream mechanisms. One well-established function of ATG13 is to recruit ATG9 vesicles (PMID: 36791199). These vesicles serve as an upstream platform for the PI3K complex, providing the substrate for phosphoinositide generation (PMID: 38342428). To clarify how our mutations impact this step, we starved ATG13-FLAG knock-in cells and observed ATG9 localization. Unexpectedly, even in FU5A knock-in cells where ATG13 is almost completely dissociated from the ULK1 complex, ATG9A still colocalized with FIP200 (revised Figure S3C). These puncta also overlapped with p62, likely because p62 bodies recruit both FIP200 and ATG9 vesicles. Although we suspect that ATG9 recruitment is nonetheless impaired under these conditions, we were unable to definitively demonstrate this experimentally and consider it an important avenue for future study.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors):</bold></p><p>Here are some additional minor suggestions:</p><p>(1) The UBL domains are only mentioned in the abstract but not anywhere else in the manuscript. I suggest the authors add descriptions related to the UBL domains in the Results section.</p></disp-quote><p>We thank the reviewer for pointing out the lack of description of UBL domains, which we added in Results in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(2) The authors may want to consider adding a diagram in Figure 1A to show the domain organization of the three full-length proteins and the ranges of the three fragments in the predicted structure.</p></disp-quote><p>We have added a proposed diagram as Figure 1A.</p><disp-quote content-type="editor-comment"><p>(3) I suggest the authors consider highlighting in Figure 1A the positions of the binding sites shown in Figure 1B, for example, by adding arrows in Figure 1A.</p></disp-quote><p>We have added arrows in the revised Figure 1B (which was Figure 1A in the original submission).</p><disp-quote content-type="editor-comment"><p>(4) In Figure 1D, &quot;Atg13-FLAG&quot; should be &quot;Atg13-FLAG FIP3A&quot;.</p></disp-quote><p>We have revised the labeling in Figure 1D.</p><disp-quote content-type="editor-comment"><p>(5) &quot;the binding of ATG13 and ULK1 to the FIP200 dimer one by one&quot; may need to be re-phrased. &quot;One by one&quot; conveys a meaning of &quot;sequential&quot;, which is probably not what the authors meant to say.</p></disp-quote><p>We have revised the sentence as “the binding of one molecule each of ATG13 and ULK1 to the FIP200 dimer”.</p><disp-quote content-type="editor-comment"><p>(6) In &quot;Wide interactions were predicted between the four molecules&quot;, I suggest changing &quot;wide&quot; to &quot;extensive&quot;.</p></disp-quote><p>We have changed “wide” to “extensive” in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(7) In &quot;which revealed that the tandem two microtubule-interacting and transport (MIT) domains in Atg1 bind to the tandem two MIT interacting motifs (MIMs) of ATG13&quot;, I suggest changing the two occurrences of &quot;tandem two&quot; to &quot;two tandem&quot; or simply &quot;tandem&quot;.</p></disp-quote><p>We simply used &quot;tandem&quot; in the revised manuscript.</p></body></sub-article></article>